{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T08:37:44Z","timestamp":1790411864433,"version":"4.1.0"},"reference-count":414,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.phrs.2016.12.003","type":"journal-article","created":{"date-parts":[[2016,12,8]],"date-time":"2016-12-08T21:31:04Z","timestamp":1481232664000},"page":"103-128","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"special_numbering":"C","title":["A story of metformin-butyrate synergism to control various pathological conditions as a consequence of gut microbiome modification: Genesis of a wonder drug?"],"prefix":"10.1016","volume":"117","author":[{"given":"Kunal","family":"Maniar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amal","family":"Moideen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankur","family":"Mittal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amol","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amitava","family":"Chakrabarti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dibyajyoti","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2016.12.003_bib0005","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1002\/pds.1802","article-title":"Trends in the prescription of anti-diabetic medications in the United Kingdom: a population-based analysis","volume":"18","author":"Filion","year":"2009","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.phrs.2016.12.003_bib0010","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/pdi.606","article-title":"Metformin: its botanical background","volume":"21","author":"Bailey","year":"2004","journal-title":"Pract. Diab. Int."},{"key":"10.1016\/j.phrs.2016.12.003_bib0015","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1172\/JCI14178","article-title":"The blooming of the French lilac","volume":"108","author":"Witters","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.phrs.2016.12.003_bib0020","unstructured":"USDA Natural Resources Conservation Service, United States Department of Agriculture, (n.d.). http:\/\/plants.usda.gov\/core\/profile?symbol=GAOF (Accessed June 7, 2016)."},{"key":"10.1016\/j.phrs.2016.12.003_bib0025","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.neulet.2009.10.026","article-title":"Activation of imidazoline I(2B) receptors by guanidine to increase glucose uptake in skeletal muscle of rats","volume":"467","author":"Chang","year":"2009","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.phrs.2016.12.003_bib0030","first-page":"1295","article-title":"Du Nouveau dans les antidiab\u00e9tiques. La NN dim\u00e9thylamino guanyl guanidine (N.N.D.G.)","volume":"36","author":"Sterne","year":"1957","journal-title":"Macro Med."},{"key":"10.1016\/j.phrs.2016.12.003_bib0035","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/BF01263443","article-title":"Biguanides","volume":"14","author":"Nattrass","year":"1978","journal-title":"Diabetologia"},{"key":"10.1016\/j.phrs.2016.12.003_bib0040","series-title":"Analogue-Based Drug Discovery 2","first-page":"47","article-title":"Standalone drugs","author":"Fischer","year":"2010"},{"issue":"Suppl. 1","key":"10.1016\/j.phrs.2016.12.003_bib0045","doi-asserted-by":"publisher","first-page":"S57","DOI":"10.1002\/dmr.5610110509","article-title":"Worldwide experience of metformin as an effective glucose-lowering agent: a meta-analysis","volume":"11","author":"Campbell","year":"1995","journal-title":"Diab. Metab. Rev."},{"key":"10.1016\/j.phrs.2016.12.003_bib0050","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1056\/NEJM199602293340906","article-title":"Metformin","volume":"334","author":"Bailey","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phrs.2016.12.003_bib0055","doi-asserted-by":"publisher","unstructured":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group, Lancet Lond. Engl. 352 (1998) 837\u2013853.","DOI":"10.1016\/S0140-6736(98)07019-6"},{"key":"10.1016\/j.phrs.2016.12.003_bib0060","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.2337\/dc12-0413","article-title":"Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"35","author":"Inzucchi","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.phrs.2016.12.003_bib0065","doi-asserted-by":"publisher","first-page":"723","DOI":"10.2337\/dc11-1468","article-title":"The 10-year cost-effectiveness of lifestyle intervention or metformin for diabetes prevention: an intent-to-treat analysis of the DPP\/DPPOS","volume":"35","author":"Diabetes Prevention Program Research Group","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.phrs.2016.12.003_bib0070","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.2337\/dc10-0843","article-title":"Cost-effectiveness of interventions to prevent and control diabetes mellitus: a systematic review","volume":"33","author":"Li","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.phrs.2016.12.003_bib0075","doi-asserted-by":"publisher","first-page":"353","DOI":"10.2337\/diabetes.48.2.353","article-title":"An insulin sensitizer improves the free radical defense system potential and insulin sensitivity in high fructose-fed rats","volume":"48","author":"Faure","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.phrs.2016.12.003_bib0080","doi-asserted-by":"publisher","first-page":"3173","DOI":"10.1073\/pnas.73.9.3173","article-title":"Insulin effect on the cell cycle: analysis of the kinetics of growth parameters in confluent chick cells","volume":"73","author":"Teng","year":"1976","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2010","key":"10.1016\/j.phrs.2016.12.003_bib0085","first-page":"315","article-title":"Insulin resistance and hyperinsulinaemia in the development and progression of cancer","volume":"118","author":"Godsland","year":"1979","journal-title":"Clin. Sci. Lond. Engl."},{"key":"10.1016\/j.phrs.2016.12.003_bib0090","doi-asserted-by":"publisher","first-page":"124","DOI":"10.2337\/dc12-0740","article-title":"The use of metformin and the incidence of lung cancer in patients with type 2 diabetes","volume":"36","author":"Smiechowski","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.phrs.2016.12.003_bib0095","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1097\/IGC.0b013e3182a80a21","article-title":"The effects of metformin on ovarian cancer: a systematic review","volume":"23","author":"Dilokthornsakul","year":"2013","journal-title":"Int. J. Gynecol. Cancer Off. J. Int. Gynecol. Cancer Soc."},{"key":"10.1016\/j.phrs.2016.12.003_bib0100","doi-asserted-by":"publisher","first-page":"2792","DOI":"10.1038\/bjc.2013.657","article-title":"The effect of metformin on apoptosis in a breast cancer presurgical trial","volume":"109","author":"Cazzaniga","year":"2013","journal-title":"Br. J. Cancer."},{"key":"10.1016\/j.phrs.2016.12.003_bib0105","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1164\/rccm.201407-1395OC","article-title":"Survival of patients with stage IV lung cancer with diabetes treated with metformin","volume":"191","author":"Lin","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.phrs.2016.12.003_bib0110","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/ajg.2011.384","article-title":"Risk of hepatocellular carcinoma in diabetic patients and risk reduction associated with anti-diabetic therapy: a population-based cohort study","volume":"107","author":"Lai","year":"2012","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.phrs.2016.12.003_bib0115","doi-asserted-by":"publisher","first-page":"150","DOI":"10.3109\/07357907.2014.889706","article-title":"Presurgical trial of metformin in overweight and obese patients with newly diagnosed breast cancer","volume":"32","author":"Kalinsky","year":"2014","journal-title":"Cancer Invest."},{"key":"10.1016\/j.phrs.2016.12.003_bib0120","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1002\/ijc.29720","article-title":"Metformin use and survival after colorectal cancer: a population-based cohort study","volume":"138","author":"Mc Menamin","year":"2016","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.phrs.2016.12.003_bib0125","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/S1470-2045(15)00027-3","article-title":"Metformin in patients with advanced pancreatic cancer: a double-blind, randomised, placebo-controlled phase 2 trial","volume":"16","author":"Kordes","year":"2015","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.phrs.2016.12.003_bib0130","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/S1470-2045(15)00565-3","article-title":"Metformin for chemoprevention of metachronous colorectal adenoma or polyps in post-polypectomy patients without diabetes: a multicentre double-blind, placebo-controlled, randomised phase 3 trial","volume":"17","author":"Higurashi","year":"2016","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.phrs.2016.12.003_bib0135","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s10552-015-0687-0","article-title":"Metformin and prostate cancer mortality: a meta-analysis","volume":"27","author":"Stopsack","year":"2016","journal-title":"Cancer Causes Control CCC"},{"key":"10.1016\/j.phrs.2016.12.003_bib0140","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s10549-012-2170-x","article-title":"Metformin and breast cancer risk: a meta-analysis and critical literature review","volume":"135","author":"Col","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.phrs.2016.12.003_bib0145","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1158\/1940-6207.CAPR-15-0048","article-title":"Effect of metformin on Breast ductal carcinoma In situ proliferation in a randomized presurgical trial","volume":"8","author":"DeCensi","year":"2015","journal-title":"Cancer Prev. Res. Phila. Pa."},{"key":"10.1016\/j.phrs.2016.12.003_bib0150","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1530\/EJE-12-0369","article-title":"Diabetes, metformin use, and colon cancer: a population-based cohort study in Taiwan","volume":"167","author":"Tseng","year":"2012","journal-title":"Eur. J. Endocrinol. Eur. Fed. Endocr. Soc."},{"key":"10.1016\/j.phrs.2016.12.003_bib0155","doi-asserted-by":"publisher","first-page":"2844","DOI":"10.1200\/JCO.2011.39.7505","article-title":"Diabetes, metformin, and breast cancer in postmenopausal women","volume":"30","author":"Chlebowski","year":"2012","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.phrs.2016.12.003_bib0160","unstructured":"A. Kritharis, J. Caplain, S. Rajagopal, E. Grimm, P. Tsichlis, R. Martell, W. Saif, A phase I study of metformin and chemotherapy in solid tumors., J. Clin. Oncol. (n.d.). http:\/\/meetinglibrary.asco.org\/content\/130976-144 (Accessed May 21, 2016)"},{"key":"10.1016\/j.phrs.2016.12.003_bib0165","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1002\/cam4.353","article-title":"Antiproliferative and metabolic effects of metformin in a preoperative window clinical trial for endometrial cancer","volume":"4","author":"Schuler","year":"2015","journal-title":"Cancer Med."},{"issue":"2008","key":"10.1016\/j.phrs.2016.12.003_bib0170","first-page":"61","article-title":"Metformin and body weight","volume":"32","author":"Golay","year":"2005","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.phrs.2016.12.003_bib0175","doi-asserted-by":"publisher","first-page":"920","DOI":"10.2337\/diacare.19.9.920","article-title":"The effect of metformin on the metabolic abnormalities associated with upper-body fat distribution. BIGPRO Study Group","volume":"19","author":"Fontbonne","year":"1996","journal-title":"Diabetes Care"},{"key":"10.1016\/j.phrs.2016.12.003_bib0180","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1210\/jc.2014-2443","article-title":"Cardiovascular risk associated with acarbose versus metformin as the first-line treatment in patients with type 2 diabetes: a nationwide cohort study","volume":"100","author":"Chang","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.phrs.2016.12.003_bib0185","doi-asserted-by":"publisher","first-page":"601","DOI":"10.7326\/0003-4819-157-9-201211060-00003","article-title":"Comparative effectiveness of sulfonylurea and metformin monotherapy on cardiovascular events in type 2 diabetes mellitus: a cohort study","volume":"157","author":"Roumie","year":"2012","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.phrs.2016.12.003_bib0190","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/j.1463-1326.2010.01349.x","article-title":"Effect of metformin on cardiovascular events and mortality: a meta-analysis of randomized clinical trials","volume":"13","author":"Lamanna","year":"2011","journal-title":"Diab. Obes. Metab."},{"key":"10.1016\/j.phrs.2016.12.003_bib0195","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/S2213-8587(15)00121-7","article-title":"Effect of metformin pretreatment on myocardial injury during coronary artery bypass surgery in patients without diabetes (MetCAB): a double-blind, randomised controlled trial","volume":"3","author":"El Messaoudi","year":"2015","journal-title":"Lancet Diab. Endocrinol."},{"key":"10.1016\/j.phrs.2016.12.003_bib0200","doi-asserted-by":"publisher","first-page":"e0145719","DOI":"10.1371\/journal.pone.0145719","article-title":"Effect of metformin treatment on lipoprotein subfractions in non-Diabetic patients with acute myocardial infarction: a glycometabolic intervention as adjunct to primary Coronary intervention in ST elevation myocardial infarction (GIPS-III) trial","volume":"11","author":"Eppinga","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2016.12.003_bib0205","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.2337\/dc12-0719","article-title":"Effects of metformin versus glipizide on cardiovascular outcomes in patients with type 2 diabetes and coronary artery disease","volume":"36","author":"Hong","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.phrs.2016.12.003_bib0210","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/S2213-8587(13)70152-9","article-title":"Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial","volume":"2","author":"Preiss","year":"2014","journal-title":"Lancet Diab. Endocrinol."},{"key":"10.1016\/j.phrs.2016.12.003_bib0215","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/ijs.12023","article-title":"Safety and feasibility of metformin in patients with impaired glucose tolerance and a recent TIA or minor ischemic stroke (LIMIT) trial \u2013 a multicenter, randomized, open-label phase II trial","volume":"10","author":"den Hertog","year":"2015","journal-title":"Int. J. Stroke Off. J. Int. Stroke Soc."},{"key":"10.1016\/j.phrs.2016.12.003_bib0220","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3892\/br.2012.18","article-title":"Metformin in non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"1","author":"Li","year":"2013","journal-title":"Biomed. Rep."},{"issue":"2010","key":"10.1016\/j.phrs.2016.12.003_bib0225","first-page":"1255","article-title":"Metformin versus dietary treatment in nonalcoholic hepatic steatosis: a randomized study","volume":"34","author":"Garinis","year":"2005","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.phrs.2016.12.003_bib0230","first-page":"999","article-title":"Metformin: non-glycemic effects and potential novel indications","volume":"22","author":"Anabtawi","year":"2016","journal-title":"Endocr. Pract. Off. J. Am. Coll. Endocrinol. Am. Assoc. Clin. Endocrinol."},{"key":"10.1016\/j.phrs.2016.12.003_bib0235","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s002840010092","article-title":"Effect of insulin on microbial growth","volume":"41","author":"Plotkin","year":"2000","journal-title":"Curr. Microbiol."},{"key":"10.1016\/j.phrs.2016.12.003_bib0240","first-page":"35","article-title":"Human recombinant insulin in supraphysiological concentration support bacterial growth in glucose independent manner","volume":"8","author":"Chakraborty","year":"2016","journal-title":"Int. J. Drug. Dev. Res."},{"key":"10.1016\/j.phrs.2016.12.003_bib0245","doi-asserted-by":"publisher","first-page":"263ra159","DOI":"10.1126\/scitranslmed.3009885","article-title":"Metformin as adjunct antituberculosis therapy","volume":"6","author":"Singhal","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.phrs.2016.12.003_bib0250","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.cell.2013.02.035","article-title":"Metformin retards aging in C. elegans by altering microbial folate and methionine metabolism","volume":"153","author":"Cabreiro","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2016.12.003_bib0255","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12967-015-0443-y","article-title":"Metformin as a potential combination therapy with existing front-line antibiotics for Tuberculosis","volume":"13","author":"Vashisht","year":"2015","journal-title":"J. Transl. Med."},{"issue":"Pt. 3","key":"10.1016\/j.phrs.2016.12.003_bib0260","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1042\/bj3480607","article-title":"Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain","volume":"348","author":"Owen","year":"2000","journal-title":"Biochem. J."},{"key":"10.1016\/j.phrs.2016.12.003_bib0265","doi-asserted-by":"publisher","first-page":"e1000864","DOI":"10.1371\/journal.ppat.1000864","article-title":"The type I NADH dehydrogenase of Mycobacterium tuberculosis counters phagosomal NOX2 activity to inhibit TNF-alpha-mediated host cell apoptosis","volume":"6","author":"Miller","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.phrs.2016.12.003_bib0270","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.redox.2014.05.006","article-title":"Mitochondrial reactive oxygen species: a double edged sword in ischemia\/reperfusion vs preconditioning","volume":"2","author":"Kalogeris","year":"2014","journal-title":"Redox Biol."},{"key":"10.1016\/j.phrs.2016.12.003_bib0275","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/BF00425185","article-title":"The concept of a bacterium","volume":"42","author":"Stanier","year":"1962","journal-title":"Arch. F\u00fcr Mikrobiol."},{"key":"10.1016\/j.phrs.2016.12.003_bib0280","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/nature13270","article-title":"Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase","volume":"510","author":"Madiraju","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2016.12.003_bib0285","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.bbabio.2012.11.014","article-title":"The function and the role of the mitochondrial glycerol-3-phosphate dehydrogenase in mammalian tissues","volume":"1827","author":"Mr\u00e1\u010dek","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.phrs.2016.12.003_bib0290","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.cmet.2014.07.013","article-title":"Control of gluconeogenesis by metformin: does redox trump energy charge?","volume":"20","author":"Baur","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.phrs.2016.12.003_bib0295","doi-asserted-by":"publisher","first-page":"3030","DOI":"10.1111\/febs.13233","article-title":"Structure and proposed mechanism of L-\u03b1-glycerophosphate oxidase from Mycoplasma pneumoniae","volume":"282","author":"Elkhal","year":"2015","journal-title":"FEBS J."},{"key":"10.1016\/j.phrs.2016.12.003_bib0300","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1146\/annurev.mi.30.100176.002535","article-title":"Glycerol dissimilation and its regulation in bacteria","volume":"30","author":"Lin","year":"1976","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.phrs.2016.12.003_bib0305","doi-asserted-by":"publisher","first-page":"219","DOI":"10.4103\/2229-5186.93029","article-title":"Study of antimicrobial property of some hypoglycemic drugs","volume":"2","author":"Dash","year":"2011","journal-title":"Chron. Young Sci."},{"key":"10.1016\/j.phrs.2016.12.003_bib0310","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.saa.2015.04.115","article-title":"Study of chemical bonding, physical and biological effect of metformin drug as an organized medicine for diabetes patients with chromium(III) and vanadium(IV) ions","volume":"149","author":"Adam","year":"2015","journal-title":"Spectrochim. Acta A Mol. Biomol. Spectrosc."},{"key":"10.1016\/j.phrs.2016.12.003_bib0315","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.2337\/db14-1225","article-title":"Metformin inhibits monocyte-to-macrophage differentiation via AMPK-mediated inhibition of STAT3 activation: potential role in atherosclerosis","volume":"64","author":"Vasamsetti","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.phrs.2016.12.003_bib0320","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/nrmicro2128","article-title":"Antimicrobial mechanisms of phagocytes and bacterial evasion strategies","volume":"7","author":"Flannagan","year":"2009","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.phrs.2016.12.003_bib0325","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2119\/molmed.2013.00065","article-title":"Activation of AMPK enhances neutrophil chemotaxis and bacterial killing","volume":"19","author":"Park","year":"2013","journal-title":"Mol. Med. Camb. Mass."},{"key":"10.1016\/j.phrs.2016.12.003_bib0330","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S1286-4579(01)01376-4","article-title":"Entry and survival of pathogenic mycobacteria in macrophages","volume":"3","author":"Pieters","year":"2001","journal-title":"Microbes Infect. Inst. Pasteur."},{"key":"10.1016\/j.phrs.2016.12.003_bib0335","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1128\/IAI.01195-10","article-title":"Listeria monocytogenes infection induces prosurvival metabolic signaling in macrophages","volume":"79","author":"Zou","year":"2011","journal-title":"Infect. Immun."},{"key":"10.1016\/j.phrs.2016.12.003_bib0340","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1111\/cmi.12279","article-title":"Mycobacterium leprae intracellular survival relies on cholesterol accumulation in infected macrophages: a potential target for new drugs for leprosy treatment","volume":"16","author":"Mattos","year":"2014","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.phrs.2016.12.003_bib0345","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1128\/CMR.00032-07","article-title":"Molecular pathogenesis of Shigella spp.: controlling host cell signaling, invasion, and death by type III secretion","volume":"21","author":"Schroeder","year":"2008","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.phrs.2016.12.003_bib0350","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/S0092-8674(00)80754-0","article-title":"A coat protein on phagosomes involved in the intracellular survival of mycobacteria","volume":"97","author":"Ferrari","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2016.12.003_bib0355","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.mehy.2014.04.002","article-title":"Statin therapy may prevent development of tuberculosis in diabetic state","volume":"83","author":"Banerjee","year":"2014","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.phrs.2016.12.003_bib0360","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1093\/infdis\/jit550","article-title":"Statin therapy reduces the mycobacterium tuberculosis burden in human macrophages and in mice by enhancing autophagy and phagosome maturation","volume":"209","author":"Parihar","year":"2014","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.phrs.2016.12.003_bib0365","doi-asserted-by":"publisher","first-page":"e75490","DOI":"10.1371\/journal.pone.0075490","article-title":"Simvastatin enhances protection against Listeria monocytogenes infection in mice by counteracting listeria-induced phagosomal escape","volume":"8","author":"Parihar","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2016.12.003_bib0370","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.bbrc.2013.08.062","article-title":"Metformin inhibits macrophage cholesterol biosynthesis rate: possible role for metformin-induced oxidative stress","volume":"439","author":"Koren-Gluzer","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.phrs.2016.12.003_bib0375","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12944-016-0281-9","article-title":"Metformin promotes cholesterol efflux in macrophages by up-regulating FGF21 expression: a novel anti-atherosclerotic mechanism","volume":"15","author":"Luo","year":"2016","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.phrs.2016.12.003_bib0380","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/B978-0-12-385855-9.00006-0","article-title":"Diabetes and tuberculosis: analysis of a paradox","volume":"53","author":"Banerjee","year":"2011","journal-title":"Adv. Clin. Chem."},{"key":"10.1016\/j.phrs.2016.12.003_bib0385","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/2251-6581-11-28","article-title":"Diabetes and tuberculosis: a review of the role of optimal glycemic control","volume":"11","author":"Niazi","year":"2012","journal-title":"J. Diab. Metab. Disord."},{"key":"10.1016\/j.phrs.2016.12.003_bib0390","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1007\/s00125-015-3844-9","article-title":"Metformin and the gastrointestinal tract","volume":"59","author":"McCreight","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/j.phrs.2016.12.003_bib0395","doi-asserted-by":"crossref","first-page":"198","DOI":"10.2337\/dc15-0488","article-title":"The primary glucose-Lowering effect of metformin resides in the gut, not the circulation: results from short-term pharmacokinetic and 12-week dose-ranging studies","volume":"39","author":"Buse","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.phrs.2016.12.003_bib0400","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/nm.3787","article-title":"Metformin activates a duodenal Ampk-dependent pathway to lower hepatic glucose production in rats","volume":"21","author":"Duca","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.phrs.2016.12.003_bib0405","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.2337\/db14-1388","article-title":"Association of organic cation transporter 1 with intolerance to metformin in type 2 diabetes: a GoDARTS study","volume":"64","author":"Dujic","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.phrs.2016.12.003_bib0410","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s002109900152","article-title":"Effects of metformin on intestinal 5-hydroxytryptamine (5-HT) release and on 5-HT3 receptors","volume":"361","author":"Cubeddu","year":"2000","journal-title":"Naunyn. Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.phrs.2016.12.003_bib0415","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s10928-015-9436-y","article-title":"Prediction and validation of enzyme and transporter off-targets for metformin","volume":"42","author":"Yee","year":"2015","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"key":"10.1016\/j.phrs.2016.12.003_bib0420","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/S0002-9343(97)00254-4","article-title":"Efficacy of metformin in type II diabetes: results of a double-blind placebo-controlled, dose-response trial","volume":"103","author":"Garber","year":"1997","journal-title":"Am. J. Med."},{"key":"10.1016\/j.phrs.2016.12.003_bib0425","doi-asserted-by":"publisher","first-page":"759","DOI":"10.2337\/diacare.29.04.06.dc05-1967","article-title":"Efficacy, tolerability, and safety of a novel once-daily extended-release metformin in patients with type 2 diabetes","volume":"29","author":"Schwartz","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.phrs.2016.12.003_bib0430","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1177\/1932296815577425","article-title":"Addition of a gastrointestinal microbiome modulator to metformin improves metformin tolerance and fasting glucose levels","volume":"9","author":"Burton","year":"2015","journal-title":"J. Diab. Sci. Technol."},{"key":"10.1016\/j.phrs.2016.12.003_bib0435","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1016\/j.jdiacomp.2015.08.023","article-title":"Gastrointestinal microbiome modulator improves glucose tolerance in overweight and obese subjects: a randomized controlled pilot trial","volume":"29","author":"Rebello","year":"2015","journal-title":"J. Diab. Complications"},{"key":"10.1016\/j.phrs.2016.12.003_bib0440","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1097\/MEG.0b013e3282f5f734","article-title":"Gastrointestinal symptoms and glycemic control in diabetes mellitus: a longitudinal population study","volume":"20","author":"Quan","year":"2008","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.phrs.2016.12.003_bib0445","doi-asserted-by":"publisher","first-page":"e9085","DOI":"10.1371\/journal.pone.0009085","article-title":"Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults","volume":"5","author":"Larsen","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2016.12.003_bib0450","doi-asserted-by":"publisher","first-page":"5935","DOI":"10.1128\/AEM.01357-14","article-title":"Effect of metformin on metabolic improvement and gut microbiota","volume":"80","author":"Lee","year":"2014","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.phrs.2016.12.003_bib0455","doi-asserted-by":"publisher","first-page":"e100778","DOI":"10.1371\/journal.pone.0100778","article-title":"Novel gut-based pharmacology of metformin in patients with type 2 diabetes mellitus","volume":"9","author":"Napolitano","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2016.12.003_bib0460","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1210\/jc.2015-3754","article-title":"Diabetes prevention program research group, long-term metformin use and vitamin B12 deficiency in the diabetes prevention program outcomes study","volume":"101","author":"Aroda","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.phrs.2016.12.003_bib0465","first-page":"BC01","article-title":"Association between serum and serum homocysteine levels in diabetic patients on metformin","volume":"10","author":"Upadhyay","year":"2016","journal-title":"J. Clin. Diagn. Res. JCDR"},{"key":"10.1016\/j.phrs.2016.12.003_bib0470","doi-asserted-by":"publisher","first-page":"17","DOI":"10.5958\/2321-1032.2015.00037.6","article-title":"Studies on homocysteine, vitamin B12 & folic acid status on patients with type 2 diabetes mellitus being treated with metformin","volume":"3","author":"Gaur","year":"2015","journal-title":"Int. J. Contemp. Med."},{"key":"10.1016\/j.phrs.2016.12.003_bib0475","doi-asserted-by":"publisher","first-page":"c2181","DOI":"10.1136\/bmj.c2181","article-title":"Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial","volume":"340","author":"de Jager","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.phrs.2016.12.003_bib0480","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.jdiacomp.2005.10.005","article-title":"Effects of metformin or rosiglitazone on serum concentrations of homocysteine, folate, and vitamin B12 in patients with type 2 diabetes mellitus","volume":"21","author":"Sahin","year":"2007","journal-title":"J. Diabetes Complications"},{"key":"10.1016\/j.phrs.2016.12.003_bib0485","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1046\/j.1365-2796.2003.01213.x","article-title":"Effects of short-term treatment with metformin on serum concentrations of homocysteine, folate and vitamin B12 in type 2 diabetes mellitus: a randomized placebo-controlled trial","volume":"254","author":"Wulffel\u00e9","year":"2003","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.phrs.2016.12.003_bib0490","doi-asserted-by":"publisher","first-page":"521","DOI":"10.3109\/00365519709084603","article-title":"Metformin increases total serum homocysteine levels in non-diabetic male patients with coronary heart disease","volume":"57","author":"Carlsen","year":"1997","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.phrs.2016.12.003_bib0495","first-page":"187","article-title":"Vitamin B 12 and folic acid serum levels in diabetics under various therapeutic regimens","volume":"2","author":"Carpentier","year":"1976","journal-title":"Diab\u00e8te M\u00e9tabolisme"},{"key":"10.1016\/j.phrs.2016.12.003_bib0500","doi-asserted-by":"publisher","first-page":"751","DOI":"10.3109\/00365527109179948","article-title":"Effects of a biguanide (Metformin) on vitamin B12 and folic acid absorption and intestinal enzyme activities","volume":"6","author":"Berchtold","year":"1971","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.phrs.2016.12.003_bib0505","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.diabet.2016.03.008","article-title":"Association between metformin and vitamin B12 deficiency in patients with type 2 diabetes: a systematic review and meta-analysis","volume":"42","author":"Chapman","year":"2016","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.phrs.2016.12.003_bib0510","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s11739-014-1157-5","article-title":"The role of metformin on vitamin B12 deficiency: a meta-analysis review","volume":"10","author":"Niafar","year":"2015","journal-title":"Intern. Emerg. Med."},{"key":"10.1016\/j.phrs.2016.12.003_bib0515","first-page":"88","article-title":"Effect of metformin and folic acid on plasma homocysteine level in type 2 diabetic patients","volume":"1","author":"Mohammadi","year":"2009","journal-title":"Int. J. Med. Med. Sci."},{"key":"10.1016\/j.phrs.2016.12.003_bib0520","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature11053","article-title":"Human gut microbiome viewed across age and geography","volume":"486","author":"Yatsunenko","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2016.12.003_bib0525","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1042\/BST0330806","article-title":"Vitamin B12: chemistry and biochemistry","volume":"33","author":"Kr\u00e4utler","year":"2005","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.phrs.2016.12.003_bib0530","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1097\/00001574-199903000-00015","article-title":"Intestinal absorption of vitamins","volume":"15","author":"Said","year":"1999","journal-title":"Curr. Opin. Gastroenterol."},{"key":"10.1016\/j.phrs.2016.12.003_bib0535","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.cell.2006.09.041","article-title":"Identification of an intestinal folate transporter and the molecular basis for hereditary folate malabsorption","volume":"127","author":"Qiu","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2016.12.003_bib0540","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nature12198","article-title":"Gut metagenome in European women with normal, impaired and diabetic glucose control","volume":"498","author":"Karlsson","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2016.12.003_bib0545","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nature11450","article-title":"A metagenome-wide association study of gut microbiota in type 2 diabetes","volume":"490","author":"Qin","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2016.12.003_bib0550","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/nature15766","article-title":"Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota","volume":"528","author":"Forslund","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2016.12.003_bib0555","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.cmet.2015.12.012","article-title":"Confounding effects of metformin on the human gut microbiome in type 2 diabetes","volume":"23","author":"Mardinoglu","year":"2016","journal-title":"Cell Metab."},{"key":"10.1016\/j.phrs.2016.12.003_bib0560","doi-asserted-by":"publisher","first-page":"e20216","DOI":"10.1371\/journal.pone.0020216","article-title":"SLC5A8 gene, a transporter of butyrate: a gut flora metabolite, is frequently methylated in African American colon adenomas","volume":"6","author":"Brim","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2016.12.003_bib0565","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1113\/expphysiol.2014.077982","article-title":"Characterization of butyrate transport across the luminal membranes of equine large intestine","volume":"99","author":"Nedjadi","year":"2014","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.phrs.2016.12.003_bib0570","doi-asserted-by":"publisher","first-page":"6734","DOI":"10.1038\/ncomms7734","article-title":"Metabolite-sensing receptors GPR43 and GPR109A facilitate dietary fibre-induced gut homeostasis through regulation of the inflammasome","volume":"6","author":"Macia","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2016.12.003_bib0575","doi-asserted-by":"publisher","first-page":"e611","DOI":"10.7717\/peerj.611","article-title":"Butyrate and other short-chain fatty acids increase the rate of lipolysis in 3T3-L1 adipocytes","volume":"2","author":"Rumberger","year":"2014","journal-title":"Peer J."},{"key":"10.1016\/j.phrs.2016.12.003_bib0580","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1472-6793-8-19","article-title":"Butyrate ingestion improves hepatic glycogen storage in the re-fed rat","volume":"8","author":"Beauvieux","year":"2008","journal-title":"BMC Physiol."},{"key":"10.1016\/j.phrs.2016.12.003_bib0585","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.2337\/db08-1637","article-title":"Butyrate improves insulin sensitivity and increases energy expenditure in mice","volume":"58","author":"Gao","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.phrs.2016.12.003_bib0590","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/nrd3483","article-title":"Metabolic disease: new role for HDACs in glucose homeostasis","volume":"10","author":"Crunkhorn","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.phrs.2016.12.003_bib0595","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1038\/nm.2744","article-title":"Hepatic Hdac3 promotes gluconeogenesis by repressing lipid synthesis and sequestration","volume":"18","author":"Sun","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.phrs.2016.12.003_bib0600","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.bbrc.2010.11.086","article-title":"The role of class I histone deacetylase (HDAC) on gluconeogenesis in liver","volume":"404","author":"Oiso","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.phrs.2016.12.003_bib0605","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.cbi.2016.06.007","article-title":"Sodium butyrate reduces insulin-resistance, fat accumulation and dyslipidemia in type-2 diabetic rat: a comparative study with metformin","volume":"254","author":"Khan","year":"2016","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.phrs.2016.12.003_bib0610","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1042\/cs0440055","article-title":"The use of human skeletal muscle in vitro for biochemical and pharmacological studies of glucose uptake","volume":"44","author":"Frayn","year":"1973","journal-title":"Clin. Sci."},{"key":"10.1016\/j.phrs.2016.12.003_bib0615","series-title":"Butyric Acid Salt of n,n-dimethyl Imidocarbon Imidic Diamide, Method of Preparing Same, and Pharmaceutical Compositions and Combinations Containing Same, US20120135952 A1","author":"Kim","year":"2012"},{"key":"10.1016\/j.phrs.2016.12.003_bib0620","doi-asserted-by":"publisher","first-page":"489","DOI":"10.2337\/diacare.24.3.489","article-title":"Effect of metformin on glucagon-like peptide 1 (GLP-1) and leptin levels in obese nondiabetic subjects","volume":"24","author":"Mannucci","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.phrs.2016.12.003_bib0625","first-page":"336","article-title":"Effects of metformin on glucagon-like peptide-1 levels in obese patients with and without Type 2 diabetes","volume":"17","author":"Mannucci","year":"2004","journal-title":"Diabetes Nutr. Metab."},{"key":"10.1016\/j.phrs.2016.12.003_bib0630","doi-asserted-by":"publisher","first-page":"10","DOI":"10.5009\/gnl.2012.6.1.10","article-title":"Gut hormones and appetite control: a focus on PYY and GLP-1 as therapeutic targets in obesity","volume":"6","author":"De Silva","year":"2012","journal-title":"Gut Liver"},{"key":"10.1016\/j.phrs.2016.12.003_bib0635","doi-asserted-by":"crossref","first-page":"E318","DOI":"10.1152\/ajpendo.00191.2010","article-title":"GLP-1 treatment reduces endogenous insulin resistance via activation of central GLP-1 receptors in mice fed a high-fat diet","volume":"299","author":"Parlevliet","year":"2010","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.phrs.2016.12.003_bib0640","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1111\/cen.12221","article-title":"GLP-1 and peptide YY secretory response after fat load is impaired by insulin resistance, impaired fasting glucose and type 2 diabetes in morbidly obese subjects","volume":"80","author":"Fern\u00e1ndez-Garc\u00eda","year":"2014","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.phrs.2016.12.003_bib0645","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.3748\/wjg.v17.i12.1519","article-title":"Potential beneficial effects of butyrate in intestinal and extraintestinal diseases","volume":"17","author":"Canani","year":"2011","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.phrs.2016.12.003_bib0650","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/j.1464-5491.1992.tb01716.x","article-title":"The effect of intravenous metformin on glucose metabolism during hyperglycaemia in type 2 diabetes","volume":"9","author":"Sum","year":"1992","journal-title":"Diabetes Med. J. Br. Diabetes Assoc."},{"key":"10.1016\/j.phrs.2016.12.003_bib0655","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1111\/j.1365-2125.1981.tb01206.x","article-title":"Metformin kinetics in healthy subjects and in patients with diabetes mellitus","volume":"12","author":"Tucker","year":"1981","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.phrs.2016.12.003_bib0660","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1007\/s00125-008-1053-5","article-title":"Metformin and the intestine","volume":"51","author":"Bailey","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/j.phrs.2016.12.003_bib0665","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1124\/dmd.107.020180","article-title":"Mechanisms underlying saturable intestinal absorption of metformin","volume":"36","author":"Proctor","year":"2008","journal-title":"Drug Metab. Dispos. Biol. Fate Chem."},{"key":"10.1016\/j.phrs.2016.12.003_bib0670","doi-asserted-by":"publisher","first-page":"64","DOI":"10.2337\/diacare.19.1.64","article-title":"The effects of high- and medium-dose metformin therapy on cardiovascular risk factors in patients with type II diabetes","volume":"19","author":"Grant","year":"1996","journal-title":"Diabetes Care"},{"key":"10.1016\/j.phrs.2016.12.003_bib0675","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1530\/EJE-14-1163","article-title":"The effect of past antibiotic exposure on diabetes risk","volume":"172","author":"Boursi","year":"2015","journal-title":"Eur. J. Endocrinol. Eur. Fed. Endocr. Soc."},{"key":"10.1016\/j.phrs.2016.12.003_bib0680","doi-asserted-by":"publisher","first-page":"3633","DOI":"10.1210\/jc.2015-2696","article-title":"Use of antibiotics and risk of type 2 diabetes: a population-based case-control study","volume":"100","author":"Mikkelsen","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.phrs.2016.12.003_bib0685","doi-asserted-by":"crossref","first-page":"9102","DOI":"10.18632\/oncotarget.6933","article-title":"High efficacy of intravesical treatment of metformin on bladder cancer in preclinical model","volume":"7","author":"Peng","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.phrs.2016.12.003_bib0690","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1080\/21505594.2015.1049807","article-title":"Histone deacetylases: targets for antifungal drug development","volume":"6","author":"Kmetzsch","year":"2015","journal-title":"Virulence"},{"key":"10.1016\/j.phrs.2016.12.003_bib0695","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.1093\/jac\/dkr358","article-title":"Sodium butyrate inhibits pathogenic yeast growth and enhances the functions of macrophages","volume":"66","author":"Nguyen","year":"2011","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.phrs.2016.12.003_bib0700","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1080\/21505594.2015.1038014","article-title":"Histone deacetylases inhibitors effects on Cryptococcus neoformans major virulence phenotypes","volume":"6","author":"Brand\u00e3o","year":"2015","journal-title":"Virulence"},{"key":"10.1016\/j.phrs.2016.12.003_bib0705","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.3945\/jn.110.123604","article-title":"A cereal-based evening meal rich in indigestible carbohydrates increases plasma butyrate the next morning","volume":"140","author":"Nilsson","year":"2010","journal-title":"J. Nutr."},{"key":"10.1016\/j.phrs.2016.12.003_bib0710","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1126\/science.1120781","article-title":"The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin","volume":"310","author":"Shaw","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.phrs.2016.12.003_bib0715","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1172\/JCI13505","article-title":"Role of AMP-activated protein kinase in mechanism of metformin action","volume":"108","author":"Zhou","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.phrs.2016.12.003_bib0720","unstructured":"The Mechanism of Metformin\u2019s (Glucophage) Lowering Fasting Glucose Levels and Hepatogluconeogenesis, (n.d.). http:\/\/www.ebmconsult.com\/articles\/metformin-hypoglycemia-mechanism-diabetes?from=pw (Accessed May 17, 2016)."},{"key":"10.1016\/j.phrs.2016.12.003_bib0725","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1172\/JCI43661","article-title":"An energetic tale of AMPK-independent effects of metformin","volume":"120","author":"Miller","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.phrs.2016.12.003_bib0730","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1126\/science.1151363","article-title":"Hepatic glucose sensing via the CREB coactivator CRTC2","volume":"319","author":"Dentin","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.phrs.2016.12.003_bib0735","doi-asserted-by":"publisher","first-page":"306","DOI":"10.2337\/db07-0381","article-title":"Metformin inhibits hepatic gluconeogenesis through AMP-activated protein kinase-dependent regulation of the orphan nuclear receptor SHP","volume":"57","author":"Kim","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.phrs.2016.12.003_bib0740","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.2337\/db09-1679","article-title":"Role of KLF15 in regulation of hepatic gluconeogenesis and metformin action","volume":"59","author":"Takashima","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.phrs.2016.12.003_bib0745","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1172\/JCI40671","article-title":"Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1\/AMPK pathway via a decrease in hepatic energy state","volume":"120","author":"Foretz","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.phrs.2016.12.003_bib0750","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/S0006-2952(01)00679-7","article-title":"Effect of metformin on fatty acid and glucose metabolism in freshly isolated hepatocytes and on specific gene expression in cultured hepatocytes","volume":"62","author":"Fulgencio","year":"2001","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.phrs.2016.12.003_bib0755","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.2337\/diabetes.51.7.2074","article-title":"Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes","volume":"51","author":"Musi","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.phrs.2016.12.003_bib0760","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1038\/nm.3372","article-title":"Single phosphorylation sites in Acc1 and Acc2 regulate lipid homeostasis and the insulin-sensitizing effects of metformin","volume":"19","author":"Fullerton","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.phrs.2016.12.003_bib0765","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.cmet.2012.03.005","article-title":"Diacylglycerol activation of protein kinase C\u03b5 and hepatic insulin resistance","volume":"15","author":"Jornayvaz","year":"2012","journal-title":"Cell Metab."},{"key":"10.1016\/j.phrs.2016.12.003_bib0770","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1007\/s00125-013-3010-1","article-title":"Metformin action in human hepatocytes: coactivation of atypical protein kinase C alters 5\u2032-AMP-activated protein kinase effects on lipogenic and gluconeogenic enzyme expression","volume":"56","author":"Sajan","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/j.phrs.2016.12.003_bib0775","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/nature11808","article-title":"Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP","volume":"494","author":"Miller","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2016.12.003_bib0780","doi-asserted-by":"publisher","first-page":"e1004202","DOI":"10.1371\/journal.pcbi.1004202","article-title":"Deciphering signaling pathway networks to understand the molecular mechanisms of metformin action","volume":"11","author":"Sun","year":"2015","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.phrs.2016.12.003_bib0785","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/S2213-8587(15)00291-0","article-title":"Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study","volume":"3","author":"Diabetes Prevention Program Research Group","year":"2015","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.phrs.2016.12.003_bib0790","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1016\/S0140-6736(09)61457-4","article-title":"10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study","volume":"374","author":"Diabetes Prevention Program Research Group","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2016.12.003_bib0795","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s00125-005-0097-z","article-title":"Indian Diabetes Prevention Programme (IDPP), The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1)","volume":"49","author":"Ramachandran","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.phrs.2016.12.003_bib0800","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.amjmed.2007.09.016","article-title":"Meta-analysis: metformin treatment in persons at risk for diabetes mellitus","volume":"121","author":"Salpeter","year":"2008","journal-title":"Am. J. Med."},{"key":"10.1016\/j.phrs.2016.12.003_bib0805","first-page":"363","article-title":"Treating prediabetes with metformin: systematic review and meta-analysis","volume":"55","author":"Lily","year":"2009","journal-title":"Can. Fam. Phys. M\u00e9decin Fam. Can."},{"key":"10.1016\/j.phrs.2016.12.003_bib0810","doi-asserted-by":"publisher","first-page":"e1001204","DOI":"10.1371\/journal.pmed.1001204","article-title":"Reappraisal of metformin efficacy in the treatment of type 2 diabetes: a meta-analysis of randomised controlled trials","volume":"9","author":"Boussageon","year":"2012","journal-title":"PLoS Med."},{"key":"10.1016\/j.phrs.2016.12.003_bib0815","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1055\/s-0032-1321878","article-title":"Metformin inhibits advanced glycation end products (AGEs)-induced renal tubular cell injury by suppressing reactive oxygen species generation via reducing receptor for AGEs (RAGE) expression","volume":"44","author":"Ishibashi","year":"2012","journal-title":"Horm. Metab. Res. Horm. Stoffwechselforschung Horm. M\u00e9tabolisme"},{"key":"10.1016\/j.phrs.2016.12.003_bib0820","doi-asserted-by":"publisher","first-page":"981","DOI":"10.2337\/db10-0655","article-title":"Tubular injury in a rat model of type 2 diabetes is prevented by metformin: a possible role of HIF-1\u03b1 expression and oxygen metabolism","volume":"60","author":"Takiyama","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.phrs.2016.12.003_bib0825","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ejphar.2010.11.029","article-title":"Insulin and metformin may prevent renal injury in young type 2 diabetic Goto-Kakizaki rats","volume":"653","author":"Louro","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phrs.2016.12.003_bib0830","first-page":"170","article-title":"Effect of fenofibrate and metformin on lipotoxicity in OLETF rat kidney","volume":"38","author":"Wang","year":"2006","journal-title":"Beijing Da Xue Xue Bao"},{"key":"10.1016\/j.phrs.2016.12.003_bib0835","unstructured":"Metformin in Kidney Disease - Full Text View - ClinicalTrials.gov, (n.d.). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02252081?term=metformin +AND+nephropathy&rank=2(Accessed May 17, 2016)"},{"key":"10.1016\/j.phrs.2016.12.003_bib0840","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3109\/15563650.2013.860985","article-title":"Metformin accumulation: lactic acidosis and high plasmatic metformin levels in a retrospective case series of 66 patients on chronic therapy","volume":"52","author":"Vecchio","year":"2014","journal-title":"Clin. Toxicol. Phila. Pa."},{"key":"10.1016\/j.phrs.2016.12.003_bib0845","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/j.1365-2265.2010.03891.x","article-title":"Diabetes, metformin and lactic acidosis","volume":"74","author":"Scale","year":"2011","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.phrs.2016.12.003_bib0850","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1111\/dme.12017","article-title":"The criteria for metformin-associated lactic acidosis: the quality of reporting in a large pharmacovigilance database","volume":"30","author":"Kajbaf","year":"2013","journal-title":"Diabetes Med. J. Br. Diabetes Assoc."},{"key":"10.1016\/j.phrs.2016.12.003_bib0855","first-page":"174","article-title":"Advantage of adjunct metformin and insulin therapy in the management of glycemia in critically ill patients. Evidence for nonoccurrence of lactic acidosis and needing to parenteral metformin","volume":"4","author":"Mojtahedzadeh","year":"2008","journal-title":"Arch. Med. Sci."},{"key":"10.1016\/j.phrs.2016.12.003_bib0860","series-title":"FDA Drug Safety Communication: FDA Revises Warnings Regarding Use of the Diabetes Medicine Metformin in Certain Patients with Reduced Kidney Function","author":"Food and Drug Administration","year":"2016"},{"key":"10.1016\/j.phrs.2016.12.003_bib0865","doi-asserted-by":"crossref","unstructured":"Type 2 diabetes in adults: management | 1-Recommendations | Guidance and guidelines | NICE, (n.d.). https:\/\/www.nice.org.uk\/guidance\/NG28\/chapter\/1-Recommendations (Accessed May 17, 2016)","DOI":"10.12968\/indn.2016.3.17"},{"issue":"2013","key":"10.1016\/j.phrs.2016.12.003_bib0870","first-page":"343560","article-title":"Pathophysiology of diabetic retinopathy","author":"Tarr","year":"2013","journal-title":"ISRN Ophthalmol."},{"key":"10.1016\/j.phrs.2016.12.003_bib0875","first-page":"607","article-title":"Metformin reduces NAD (P) H oxidase activity in mouse cultured podocytes through purinergic dependent mechanism by increasing extracellular ATP concentration","volume":"60","author":"Piwkowska","year":"2013","journal-title":"Acta Biochim. Pol."},{"key":"10.1016\/j.phrs.2016.12.003_bib0880","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.2337\/diabetes.54.4.1123","article-title":"Metformin prevents glucose-induced protein kinase C-beta2 activation in human umbilical vein endothelial cells through an antioxidant mechanism","volume":"54","author":"Gallo","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.phrs.2016.12.003_bib0885","doi-asserted-by":"publisher","first-page":"e0119708","DOI":"10.1371\/journal.pone.0119708","article-title":"Anti-angiogenic effect of metformin in mouse oxygen-induced retinopathy is mediated by reducing levels of the vascular endothelial growth factor receptor Flk-1","volume":"10","author":"Joe","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2016.12.003_bib0890","unstructured":"Comparison of Diabetes Retinopathy Among Type 2 Diabetic Patients Treated With Different Regimens - Full Text View - ClinicalTrials.gov, (n.d.). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02587741?term=metformin+AND+retinopathy&rank=1(Accessed May 17, 2016)."},{"key":"10.1016\/j.phrs.2016.12.003_bib0895","article-title":"Metformin ameliorates podocyte damage by restoring renal tissue nephrin expression in type 2 diabetic rats","author":"Zhai","year":"2016","journal-title":"J. Diabetes"},{"key":"10.1016\/j.phrs.2016.12.003_bib0900","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/sj.ki.5000028","article-title":"Butyrate modulates TGF-beta1 generation and function: potential renal benefit for Acacia(sen) SUPERGUM (gum arabic)?","volume":"69","author":"Matsumoto","year":"2006","journal-title":"Kidney Int."},{"key":"10.1016\/j.phrs.2016.12.003_bib0905","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1056\/NEJMra041536","article-title":"Polycystic ovary syndrome","volume":"352","author":"Ehrmann","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phrs.2016.12.003_bib0910","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1046\/j.1365-2265.2003.01842.x","article-title":"The pathophysiology of polycystic ovary syndrome","volume":"60","author":"Tsilchorozidou","year":"2004","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.phrs.2016.12.003_bib0915","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1210\/jc.2004-1045","article-title":"Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome","volume":"90","author":"Apridonidze","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.phrs.2016.12.003_bib0920","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1016\/j.fertnstert.2004.11.070","article-title":"Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment","volume":"83","author":"DeUgarte","year":"2005","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.phrs.2016.12.003_bib0925","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/S0015-0282(16)55307-2","article-title":"Puberty and polycystic ovarian syndrome: the insulin\/insulin-like growth factor I hypothesis","volume":"58","author":"Nobels","year":"1992","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.phrs.2016.12.003_bib0930","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1159\/000341679","article-title":"Pathophysiology of polycystic ovary syndrome: the role of hyperandrogenism","volume":"40","author":"Catteau-Jonard","year":"2013","journal-title":"Front. Horm. Res."},{"key":"10.1016\/j.phrs.2016.12.003_bib0935","first-page":"55","article-title":"Impact of metformin on reproductive tissues: an overview from gametogenesis to gestation","volume":"2","author":"Bertoldo","year":"2014","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.phrs.2016.12.003_bib0940","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/0026-0495(94)90209-7","article-title":"Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure while facilitating normal menses and pregnancy","volume":"43","author":"Velazquez","year":"1994","journal-title":"Metabolism"},{"key":"10.1016\/j.phrs.2016.12.003_bib0945","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0015-0282(02)04554-5","article-title":"A systematic review of the reproductive system effects of metformin in patients with polycystic ovary syndrome","volume":"79","author":"Costello","year":"2003","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.phrs.2016.12.003_bib0950","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1093\/humrep\/dem426","article-title":"Consensus on infertility treatment related to polycystic ovary syndrome","volume":"23","author":"Thessaloniki ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2008","journal-title":"Hum. Reprod. Oxf. Engl."},{"key":"10.1016\/j.phrs.2016.12.003_bib0955","first-page":"CD003053","article-title":"Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility","volume":"5","author":"Tang","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.phrs.2016.12.003_bib0960","first-page":"CD006105","article-title":"Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome","volume":"11","author":"Tso","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.phrs.2016.12.003_bib0965","first-page":"CD005552","article-title":"Insulin-sensitising drugs versus the combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary syndrome","author":"Costello","year":"2007","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.phrs.2016.12.003_bib0970","first-page":"CD003053","article-title":"Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome","author":"Lord","year":"2003","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.phrs.2016.12.003_bib0975","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S1701-2163(15)30879-3","article-title":"Maternal and perinatal outcomes of extreme obesity in pregnancy","volume":"35","author":"Crane","year":"2013","journal-title":"J. Obstet. Gynaecol. Can. JOGC J. Obst\u00e9trique Gyn\u00e9cologie Can. JOGC"},{"key":"10.1016\/j.phrs.2016.12.003_bib0980","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/1471-2393-10-56","article-title":"The risk of adverse pregnancy outcomes in women who are overweight or obese","volume":"10","author":"Athukorala","year":"2010","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.phrs.2016.12.003_bib0985","first-page":"3271","article-title":"The decrease in luteinizing hormone secretion in response to weight reduction is inversely related to the severity of insulin resistance in overweight women","volume":"85","author":"B\u00fctzow","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.phrs.2016.12.003_bib0990","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0889-8545(05)70187-X","article-title":"Obesity and weight loss in polycystic ovary syndrome","volume":"28","author":"Hoeger","year":"2001","journal-title":"Obstet. Gynecol. Clin. North Am."},{"key":"10.1016\/j.phrs.2016.12.003_bib0995","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.ogc.2009.03.002","article-title":"Obesity and its relationship to infertility in men and women","volume":"36","author":"Loret de Mola","year":"2009","journal-title":"Obstet. Gynecol. Clin. North Am."},{"key":"10.1016\/j.phrs.2016.12.003_bib1000","doi-asserted-by":"publisher","first-page":"726","DOI":"10.2337\/dc08-0494","volume":"32","author":"Goldberg","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.phrs.2016.12.003_bib1005","first-page":"714","article-title":"Metformin versus metformin plus rosiglitazone in women with polycystic ovary syndrome","volume":"124","author":"Liao","year":"2011","journal-title":"Chin. Med. J. (Engl.)"},{"key":"10.1016\/j.phrs.2016.12.003_bib1010","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1111\/j.1365-2265.2010.03917.x","article-title":"Metformin vs thiazolidinediones for treatment of clinical, hormonal and metabolic characteristics of polycystic ovary syndrome: a meta-analysis","volume":"74","author":"Li","year":"2011","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.phrs.2016.12.003_bib1015","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1185\/03007995.2012.681636","article-title":"A systematic review and meta-analysis of randomized controlled trials comparing pioglitazone versus metformin in the treatment of polycystic ovary syndrome","volume":"28","author":"Du","year":"2012","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.phrs.2016.12.003_bib1020","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1477-7827-12-3","article-title":"Metformin and gonadotropins for ovulation induction in patients with polycystic ovary syndrome: a systematic review with meta-analysis of randomized controlled trials","volume":"12","author":"Palomba","year":"2014","journal-title":"Reprod. Biol. Endocrinol. RBE"},{"key":"10.1016\/j.phrs.2016.12.003_bib1025","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1093\/humupd\/dmv025","article-title":"Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis","volume":"21","author":"Naderpoor","year":"2015","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.phrs.2016.12.003_bib1030","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s13643-015-0105-4","article-title":"The effectiveness and safety of treatments used for polycystic ovarian syndrome management in adolescents: a systematic review and network meta-analysis protocol","volume":"4","author":"Al Khalifah","year":"2015","journal-title":"Syst. Rev."},{"key":"10.1016\/j.phrs.2016.12.003_bib1035","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/j.1479-828X.2010.01274.x","article-title":"Metformin is a reasonable first-line treatment option for non-obese women with infertility related to anovulatory polycystic ovary syndrome\u2013a meta-analysis of randomised trials","volume":"51","author":"Johnson","year":"2011","journal-title":"Aust. N. Z. J. Obstet. Gynaecol."},{"key":"10.1016\/j.phrs.2016.12.003_bib1040","doi-asserted-by":"publisher","first-page":"e49553","DOI":"10.1371\/journal.pone.0049553","article-title":"The anti-epileptic drug valproic acid (VPA) inhibits steroidogenesis in bovine theca and granulosa cells in vitro","volume":"7","author":"Glister","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2016.12.003_bib1045","series-title":"Differ. Perspect. Common Syndr. Res. PCOS","article-title":"The gut microbiome is altered in a mouse model of polycystic ovary syndrome","author":"Varykina Thackray","year":"2016"},{"key":"10.1016\/j.phrs.2016.12.003_bib1050","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/S0140-6736(14)60460-8","article-title":"Global, regional, and national prevalence of overweight and obesity in children and adults during 1980\u20132013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"384","author":"Ng","year":"2014","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.phrs.2016.12.003_bib1055","first-page":"1","article-title":"Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement","volume":"8","author":"Avenell","year":"2004","journal-title":"Health Technol. Assess. Winch. Engl."},{"key":"10.1016\/j.phrs.2016.12.003_bib1060","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3132\/dvdr.2005.017","article-title":"All obese individuals are not created equal: insulin resistance is the major determinant of cardiovascular disease in overweight\/obese individuals","volume":"2","author":"Reaven","year":"2005","journal-title":"Diab. Vasc. Dis. Res."},{"key":"10.1016\/j.phrs.2016.12.003_bib1065","doi-asserted-by":"publisher","first-page":"386","DOI":"10.7326\/0003-4819-147-6-200709180-00178","article-title":"Systematic review: comparative effectiveness and safety of oral medications for type 2 diabetes mellitus","volume":"147","author":"Bolen","year":"2007","journal-title":"Ann. Intern. Med."},{"issue":"2015","key":"10.1016\/j.phrs.2016.12.003_bib1070","first-page":"81486","article-title":"In vitro and In vivo effects of metformin on osteopontin expression in mice adipose-Derived multipotent stromal cells and adipose tissue","volume":"9","author":"\u015amieszek","year":"2015","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.phrs.2016.12.003_bib1075","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1677\/JOE-08-0278","article-title":"Metformin induces oxidative stress in white adipocytes and raises uncoupling protein 2 levels","volume":"199","author":"Anedda","year":"2008","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.phrs.2016.12.003_bib1080","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1172\/JCI117936","article-title":"Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance","volume":"95","author":"Hotamisligil","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.phrs.2016.12.003_bib1085","doi-asserted-by":"publisher","first-page":"123","DOI":"10.4110\/in.2013.13.4.123","article-title":"Metformin down-regulates TNF-\u03b1 secretion via suppression of scavenger receptors in macrophages","volume":"13","author":"Hyun","year":"2013","journal-title":"Immune Netw."},{"key":"10.1016\/j.phrs.2016.12.003_bib1090","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1677\/jme.1.02061","article-title":"Metformin reduces lipolysis in primary rat adipocytes stimulated by tumor necrosis factor-alpha or isoproterenol","volume":"37","author":"Ren","year":"2006","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.phrs.2016.12.003_bib1095","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3109\/13813455.2010.550925","article-title":"Metformin counters both lipolytic\/inflammatory agents-decreased hormone sensitive lipase phosphorylation at Ser-554 and -induced lipolysis in human adipocytes","volume":"117","author":"Grisouard","year":"2011","journal-title":"Arch. Physiol. Biochem."},{"key":"10.1016\/j.phrs.2016.12.003_bib1100","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/j.1464-5491.1989.tb01156.x","article-title":"The effects of metformin on adipocyte insulin action and metabolic control in obese subjects with type 2 diabetes","volume":"6","author":"Pedersen","year":"1989","journal-title":"Diabetes Med. J. Br. Diabetes Assoc."},{"key":"10.1016\/j.phrs.2016.12.003_bib1105","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/j.1463-1326.2009.01169.x","article-title":"Metformin induces glucose uptake in human preadipocyte-derived adipocytes from various fat depots","volume":"12","author":"Fischer","year":"2010","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.phrs.2016.12.003_bib1110","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1016\/j.bcp.2010.08.021","article-title":"Mechanisms of metformin action on glucose transport and metabolism in human adipocytes","volume":"80","author":"Grisouard","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.phrs.2016.12.003_bib1115","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1177\/1535370214537746","article-title":"Metformin prevents LYRM1-induced insulin resistance in 3T3-L1 adipocytes via a mitochondrial-dependent mechanism","volume":"239","author":"Qin","year":"2014","journal-title":"Exp. Biol. Med. Maywood NJ."},{"key":"10.1016\/j.phrs.2016.12.003_bib1120","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1159\/000324582","article-title":"In vitro and in vivo effects of metformin on human adipose tissue adiponectin","volume":"4","author":"Zulian","year":"2011","journal-title":"Obes. Facts"},{"key":"10.1016\/j.phrs.2016.12.003_bib1125","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1677\/joe.1.05646","article-title":"Metformin inhibits leptin secretion via a mitogen-activated protein kinase signalling pathway in brown adipocytes","volume":"183","author":"Klein","year":"2004","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.phrs.2016.12.003_bib1130","doi-asserted-by":"publisher","first-page":"260","DOI":"10.2337\/diabetes.52.2.260","article-title":"Effects of free fatty acids per se on glucose production, gluconeogenesis, and glycogenolysis","volume":"52","author":"Staehr","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.phrs.2016.12.003_bib1135","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/j.1463-1326.2004.00306.x","article-title":"Effects of short-term metformin treatment on insulin sensitivity of blood glucose and free fatty acids","volume":"6","author":"Iannello","year":"2004","journal-title":"Diabetes Obes. Metab."},{"issue":"2012","key":"10.1016\/j.phrs.2016.12.003_bib1140","first-page":"e394623","article-title":"Effects of metformin on the regulation of free fatty acids in insulin resistance: a double-Blind, placebo-controlled study","author":"Castro Cabezas","year":"2012","journal-title":"J. Nutr. Metab."},{"key":"10.1016\/j.phrs.2016.12.003_bib1145","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/j.1550-8528.1998.tb00314.x","article-title":"Metformin decreases food consumption and induces weight loss in subjects with obesity with type II non-insulin-dependent diabetes","volume":"6","author":"Lee","year":"1998","journal-title":"Obes. Res."},{"key":"10.1016\/j.phrs.2016.12.003_bib1150","doi-asserted-by":"publisher","first-page":"716","DOI":"10.2337\/diabetes.55.03.06.db05-0917","article-title":"Metformin restores leptin sensitivity in high-fat-fed obese rats with leptin resistance","volume":"55","author":"Kim","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.phrs.2016.12.003_bib1155","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1210\/en.2006-1237","article-title":"Metformin inhibits adenosine 5\u2032-monophosphate-activated kinase activation and prevents increases in neuropeptide Y expression in cultured hypothalamic neurons","volume":"148","author":"Chau-Van","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.phrs.2016.12.003_bib1160","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/dom.12021","article-title":"Metformin directly inhibits ghrelin secretion through AMP-activated protein kinase in rat primary gastric cells","volume":"15","author":"Gagnon","year":"2013","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.phrs.2016.12.003_bib1165","doi-asserted-by":"publisher","first-page":"4610","DOI":"10.1210\/en.2011-1485","article-title":"Mechanisms underlying metformin-induced secretion of glucagon-like peptide-1 from the intestinal L cell","volume":"152","author":"Mulherin","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.phrs.2016.12.003_bib1170","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1370\/afm.343","article-title":"Metformin as treatment for overweight and obese adults: a systematic review","volume":"3","author":"Levri","year":"2005","journal-title":"Ann. Fam. Med."},{"key":"10.1016\/j.phrs.2016.12.003_bib1175","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1046\/j.1463-1326.2002.00181.x","article-title":"Evaluation of the safety and efficacy of sibutramine, orlistat and metformin in the treatment of obesity","volume":"4","author":"Gokcel","year":"2002","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.phrs.2016.12.003_bib1180","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1053\/meta.2001.24192","article-title":"Metformin reduces weight, centripetal obesity, insulin, leptin, and low-density lipoprotein cholesterol in nondiabetic, morbidly obese subjects with body mass index greater than 30","volume":"50","author":"Glueck","year":"2001","journal-title":"Metabolism"},{"key":"10.1016\/j.phrs.2016.12.003_bib1185","doi-asserted-by":"publisher","unstructured":"The Diabetes Prevention Program: baseline characteristics of the randomized cohort. The Diabetes Prevention Program Research Group, Diabetes Care. 23 (2000) 1619\u20131629","DOI":"10.2337\/diacare.23.11.1619"},{"key":"10.1016\/j.phrs.2016.12.003_bib1190","doi-asserted-by":"publisher","first-page":"E55","DOI":"10.1542\/peds.107.4.e55","article-title":"The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes","volume":"107","author":"Freemark","year":"2001","journal-title":"Pediatrics"},{"key":"10.1016\/j.phrs.2016.12.003_bib1195","doi-asserted-by":"publisher","first-page":"790","DOI":"10.2337\/dc06-1554","article-title":"Glimepiride versus metformin as monotherapy in pediatric patients with type 2 diabetes: a randomized, single-blind comparative study","volume":"30","author":"Gottschalk","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.phrs.2016.12.003_bib1200","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1210\/jc.2012-2710","article-title":"Metformin in obese children and adolescents: the MOCA trial","volume":"98","author":"Kendall","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.phrs.2016.12.003_bib1205","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1515\/jpem-2011-0450","article-title":"Metformin use in children with obesity and normal glucose tolerance\u2013effects on cardiovascular markers and intrahepatic fat","volume":"25","author":"Mauras","year":"2012","journal-title":"J. Pediatr. Endocrinol. Metab. JPEM"},{"key":"10.1016\/j.phrs.2016.12.003_bib1210","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1111\/dom.12426","article-title":"Effects of metformin on energy intake and satiety in obese children","volume":"17","author":"Adeyemo","year":"2015","journal-title":"Diabetes Obes. Metab."},{"issue":"2014","key":"10.1016\/j.phrs.2016.12.003_bib1215","first-page":"381231","article-title":"Effect of metformin intervention during pregnancy on the gestational diabetes mellitus in women with polycystic ovary syndrome: a systematic review and meta-analysis","author":"Zhuo","year":"2014","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.phrs.2016.12.003_bib1220","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1056\/NEJMoa1509819","article-title":"Metformin versus placebo in obese pregnant women without diabetes mellitus","volume":"374","author":"Syngelaki","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phrs.2016.12.003_bib1225","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.2337\/dc11-0660","article-title":"Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition at 2 years of age","volume":"34","author":"Rowan","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.phrs.2016.12.003_bib1230","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1176\/appi.ajp.2013.13060771","article-title":"Metformin for antipsychotic-related weight gain and metabolic abnormalities: when, for whom, and for how long?","volume":"170","author":"Correll","year":"2013","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.phrs.2016.12.003_bib1235","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1136\/eb-2014-101760","article-title":"Metformin for weight loss in schizophrenia: safe but not a panacea","volume":"17","author":"Tek","year":"2014","journal-title":"Evid. Based Ment. Health"},{"key":"10.1016\/j.phrs.2016.12.003_bib1240","doi-asserted-by":"publisher","first-page":"12676","DOI":"10.1038\/srep12676","article-title":"Sodium butyrate alleviates adipocyte inflammation by inhibiting NLRP3 pathway","volume":"5","author":"Wang","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2016.12.003_bib1245","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1097\/MCO.0b013e32833eebe5","article-title":"Butyrate and other short-chain fatty acids as modulators of immunity: what relevance for health?","volume":"13","author":"Meijer","year":"2010","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"10.1016\/j.phrs.2016.12.003_bib1250","doi-asserted-by":"publisher","first-page":"81","DOI":"10.4161\/21623945.2014.960694","article-title":"Propionic acid and butyric acid inhibit lipolysis and de novo lipogenesis and increase insulin-stimulated glucose uptake in primary rat adipocytes","volume":"4","author":"Heimann","year":"2015","journal-title":"Adipocyte"},{"key":"10.1016\/j.phrs.2016.12.003_bib1255","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.2337\/db14-1213","article-title":"Short-Chain fatty acids protect against high-Fat diet-Induced obesity via a PPAR\u03b3-Dependent switch from lipogenesis to fat oxidation","volume":"64","author":"den Besten","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.phrs.2016.12.003_bib1260","doi-asserted-by":"publisher","first-page":"14663","DOI":"10.1074\/jbc.M109.081679","article-title":"Redundant control of adipogenesis by histone deacetylases 1 and 2","volume":"285","author":"Haberland","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2016.12.003_bib1265","doi-asserted-by":"crossref","first-page":"5722","DOI":"10.1016\/S0021-9258(19)39423-2","article-title":"Sodium butyrate in combination with insulin or dexamethasone can terminally differentiate actively proliferating Swiss 3T3 cells into adipocytes","volume":"265","author":"Toscani","year":"1990","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2016.12.003_bib1270","doi-asserted-by":"publisher","first-page":"G739","DOI":"10.1152\/ajpgi.00432.2010","article-title":"Activated AMPK inhibits PPAR-{alpha} and PPAR-{gamma} transcriptional activity in hepatoma cells","volume":"301","author":"Sozio","year":"2011","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.phrs.2016.12.003_bib1275","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1038\/ncomms2852","article-title":"The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43","volume":"4","author":"Kimura","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2016.12.003_bib1280","doi-asserted-by":"publisher","first-page":"e35240","DOI":"10.1371\/journal.pone.0035240","article-title":"Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms","volume":"7","author":"Lin","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2016.12.003_bib1285","doi-asserted-by":"publisher","first-page":"319","DOI":"10.4142\/jvs.2011.12.4.319","article-title":"Butyrate regulates leptin expression through different signaling pathways in adipocytes","volume":"12","author":"Soliman","year":"2011","journal-title":"J. Vet. Sci."},{"issue":"Suppl. 2","key":"10.1016\/j.phrs.2016.12.003_bib1290","doi-asserted-by":"publisher","first-page":"S157","DOI":"10.2337\/dc09-S302","article-title":"Skeletal muscle insulin resistance is the primary defect in type 2 diabetes","volume":"32","author":"DeFronzo","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.phrs.2016.12.003_bib1295","doi-asserted-by":"publisher","first-page":"E179","DOI":"10.1152\/ajpendo.00392.2009","article-title":"AICAR and metformin, but not exercise, increase muscle glucose transport through AMPK-, ERK-, and PDK1-dependent activation of atypical PKC","volume":"298","author":"Sajan","year":"2010","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.phrs.2016.12.003_bib1300","doi-asserted-by":"publisher","first-page":"20088","DOI":"10.1074\/jbc.M111.330746","article-title":"Defining the contribution of AMP-activated protein kinase (AMPK) and protein kinase C (PKC) in regulation of glucose uptake by metformin in skeletal muscle cells","volume":"287","author":"Turban","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2016.12.003_bib1305","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.3892\/ijmm.2015.2187","article-title":"Metformin attenuates palmitic acid-induced insulin resistance in L6 cells through the AMP-activated protein kinase\/sterol regulatory element-binding protein-1c pathway","volume":"35","author":"Wu","year":"2015","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.phrs.2016.12.003_bib1310","first-page":"1850","article-title":"PGC-1 mediates the regulation of metformin in muscle irisin expression and function","volume":"7","author":"Yang","year":"2015","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.phrs.2016.12.003_bib1315","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s11010-010-0649-5","article-title":"Over-expression of LYRM1 inhibits glucose transport in rat skeletal muscles via attenuated phosphorylation of PI3 K (p85) and Akt","volume":"348","author":"Kou","year":"2011","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.phrs.2016.12.003_bib1320","doi-asserted-by":"publisher","first-page":"732","DOI":"10.2337\/db12-0548","article-title":"Inhibition of class I histone deacetylases unveils a mitochondrial signature and enhances oxidative metabolism in skeletal muscle and adipose tissue","volume":"62","author":"Galmozzi","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.phrs.2016.12.003_bib1325","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3322\/caac.20078","article-title":"Diabetes and cancer: a consensus report","volume":"60","author":"Giovannucci","year":"2010","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.phrs.2016.12.003_bib1330","doi-asserted-by":"publisher","first-page":"680","DOI":"10.2337\/diab.26.7.680","article-title":"Insulin binding in diabetes: relationships with plasma insulin levels and insulin sensitivity","volume":"26","author":"Olefsky","year":"1977","journal-title":"Diabetes"},{"key":"10.1016\/j.phrs.2016.12.003_bib1335","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1136\/bmj.38415.708634.F7","article-title":"Metformin and reduced risk of cancer in diabetic patients","volume":"330","author":"Evans","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.phrs.2016.12.003_bib1340","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1146\/annurev-med-062613-093128","article-title":"Metformin in cancer treatment and prevention","volume":"66","author":"Morales","year":"2015","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.phrs.2016.12.003_bib1345","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ejphar.2013.02.038","article-title":"Metformin and cancer","volume":"705","author":"Rizos","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phrs.2016.12.003_bib1350","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/978-3-642-38007-5_21","article-title":"New perspective for an old antidiabetic drug: metformin as anticancer agent","volume":"159","author":"Leone","year":"2014","journal-title":"Cancer Treat. Res."},{"key":"10.1016\/j.phrs.2016.12.003_bib1355","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.2337\/db14-1132","article-title":"Metformin and rapamycin reduce pancreatic cancer growth in obese prediabetic mice by distinct microRNA-regulated mechanisms","volume":"64","author":"Cifarelli","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.phrs.2016.12.003_bib1360","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1126\/science.123.3191.309","article-title":"On the origin of cancer cells","volume":"123","author":"Warburg","year":"1956","journal-title":"Science"},{"key":"10.1016\/j.phrs.2016.12.003_bib1365","doi-asserted-by":"publisher","first-page":"367","DOI":"10.4161\/cc.11.2.18813","article-title":"Metformin targets Stat3 to inhibit cell growth and induce apoptosis in triple-negative breast cancers","volume":"11","author":"Deng","year":"2012","journal-title":"Cell Cycle Georget. Tex."},{"key":"10.1016\/j.phrs.2016.12.003_bib1370","doi-asserted-by":"publisher","first-page":"2714","DOI":"10.1158\/1078-0432.CCR-13-2613","article-title":"Metformin sensitizes EGFR-TKI-resistant human lung cancer cells in vitro and in vivo through inhibition of IL-6 signaling and EMT reversal","volume":"20","author":"Li","year":"2014","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.phrs.2016.12.003_bib1375","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.ccr.2013.01.009","article-title":"The LKB1-AMPK pathway-friend or foe in cancer?","volume":"23","author":"Hardie","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.phrs.2016.12.003_bib1380","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.ccr.2012.12.008","article-title":"LKB1 inactivation dictates therapeutic response of non-small cell lung cancer to the metabolism drug phenformin","volume":"23","author":"Shackelford","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.phrs.2016.12.003_bib1385","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/j.1365-2184.2007.00498.x","article-title":"Overexpression of fatty acid synthase gene activates HER1\/HER2 tyrosine kinase receptors in human breast epithelial cells","volume":"41","author":"Vazquez-Martin","year":"2008","journal-title":"Cell Prolif."},{"key":"10.1016\/j.phrs.2016.12.003_bib1390","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/j.bbrc.2015.03.148","article-title":"DEPTOR-related mTOR suppression is involved in metformin\u2019s anti-cancer action in human liver cancer cells","volume":"460","author":"Obara","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.phrs.2016.12.003_bib1395","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1073\/pnas.1221055110","article-title":"Metformin inhibits the inflammatory response associated with cellular transformation and cancer stem cell growth","volume":"110","author":"Hirsch","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.phrs.2016.12.003_bib1400","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1093\/carcin\/bgu001","article-title":"Paradoxic effects of metformin on endothelial cells and angiogenesis","volume":"35","author":"Dallaglio","year":"2014","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.phrs.2016.12.003_bib1405","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.2337\/dc12-0788","article-title":"Metformin and the risk of cancer: time-related biases in observational studies","volume":"35","author":"Suissa","year":"2012","journal-title":"Diabetes Care."},{"key":"10.1016\/j.phrs.2016.12.003_bib1410","doi-asserted-by":"crossref","first-page":"40767","DOI":"10.18632\/oncotarget.8194","article-title":"Repurposing metformin for cancer treatment: current clinical studies","volume":"7","author":"Chae","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.phrs.2016.12.003_bib1415","first-page":"47","article-title":"Histone deacetylase inhibitors (HDACIs): multitargeted anticancer agents","volume":"7","author":"Ververis","year":"2013","journal-title":"Biol. Targets Ther."},{"key":"10.1016\/j.phrs.2016.12.003_bib1420","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/j.1440-1746.2006.04213.x","article-title":"Does butyrate protect from colorectal cancer?","volume":"21","author":"Sengupta","year":"2006","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.phrs.2016.12.003_bib1425","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/bjc.1996.78","article-title":"Genes related to growth and invasiveness are repressed by sodium butyrate in ovarian carcinoma cells","volume":"73","author":"Krupitza","year":"1996","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.phrs.2016.12.003_bib1430","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s00432-006-0092-x","article-title":"The effects of short-chain fatty acids on colon epithelial proliferation and survival depend on the cellular phenotype","volume":"132","author":"Comalada","year":"2006","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.phrs.2016.12.003_bib1435","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.mrrev.2009.04.001","article-title":"Mechanisms of primary cancer prevention by butyrate and other products formed during gut flora-mediated fermentation of dietary fibre","volume":"682","author":"Scharlau","year":"2009","journal-title":"Mutat. Res."},{"key":"10.1016\/j.phrs.2016.12.003_bib1440","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.1002\/ijc.25599","article-title":"Butyrate elicits a metabolic switch in human colon cancer cells by targeting the pyruvate dehydrogenase complex","volume":"128","author":"Blouin","year":"2011","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.phrs.2016.12.003_bib1445","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/sj.onc.1205108","article-title":"Histone deacetylases inhibitors as anti-angiogenic agents altering vascular endothelial growth factor signaling","volume":"21","author":"Deroanne","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.phrs.2016.12.003_bib1450","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.4161\/cc.5.21.3409","article-title":"Effects of histone deacetylase inhibitors on HIF-13","volume":"5","author":"Liang","year":"2006","journal-title":"Cell Cycle Georget. Tex."},{"key":"10.1016\/j.phrs.2016.12.003_bib1455","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.molcel.2012.08.033","article-title":"The Warburg effect dictates the mechanism of butyrate-mediated histone acetylation and cell proliferation","volume":"48","author":"Donohoe","year":"2012","journal-title":"Mol. Cell"},{"key":"10.1016\/j.phrs.2016.12.003_bib1460","doi-asserted-by":"crossref","first-page":"38500","DOI":"10.18632\/oncotarget.9522","article-title":"Enhanced anti-tumor activity and cytotoxic effect on cancer stem cell population of metformin-butyrate compared with metformin HCl in breast cancer","volume":"7","author":"Lee","year":"2016","journal-title":"Oncotarget."},{"key":"10.1016\/j.phrs.2016.12.003_bib1465","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.2337\/dc08-2175","article-title":"New users of metformin are at low risk of incident cancer","volume":"32","author":"Libby","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.phrs.2016.12.003_bib1470","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.1007\/s00125-012-2653-7","article-title":"Cancer outcomes and all-cause mortality in adults allocated to metformin: systematic review and collaborative meta-analysis of randomised clinical trials","volume":"55","author":"Stevens","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.phrs.2016.12.003_bib1475","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/S0016-5085(98)70599-2","article-title":"Steatohepatitis: a tale of two hits?","volume":"114","author":"Day","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.phrs.2016.12.003_bib1480","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.jnutbio.2007.10.001","article-title":"The role of fatty acids in the development and progression of nonalcoholic fatty liver disease","volume":"19","author":"Gentile","year":"2008","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.phrs.2016.12.003_bib1485","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1079\/BJN20041213","article-title":"Adipokines: inflammation and the pleiotropic role of white adipose tissue","volume":"92","author":"Trayhurn","year":"2004","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.phrs.2016.12.003_bib1490","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.cell.2009.03.016","article-title":"Metformin and insulin suppress hepatic gluconeogenesis through phosphorylation of CREB binding protein","volume":"137","author":"He","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2016.12.003_bib1495","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1210\/jc.2002-021394","article-title":"Metformin rapidly increases insulin receptor activation in human liver and signals preferentially through insulin-receptor substrate-2","volume":"88","author":"Gunton","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.phrs.2016.12.003_bib1500","first-page":"507","article-title":"SREBP-1c regulated by the insulin and AMPK signaling pathways, plays a role in nonalcoholic fatty liver disease","volume":"21","author":"Kohjima","year":"2008","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.phrs.2016.12.003_bib1505","first-page":"882","article-title":"Effect of metformin on the expression of SIRT1 and UCP2 in rat liver of type 2 diabetes mellitus and nonalcoholic fatty liver","volume":"38","author":"Xu","year":"2013","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"key":"10.1016\/j.phrs.2016.12.003_bib1510","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1038\/79697","article-title":"Metformin reverses fatty liver disease in obese, leptin-deficient mice","volume":"6","author":"Lin","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.phrs.2016.12.003_bib1515","doi-asserted-by":"publisher","first-page":"G739","DOI":"10.1152\/ajpgi.00432.2010","article-title":"Activated AMPK inhibits PPAR-{alpha} and PPAR-{gamma} transcriptional activity in hepatoma cells","volume":"301","author":"Sozio","year":"2011","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.phrs.2016.12.003_bib1520","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1038\/ncb1404","article-title":"APPL1 binds to adiponectin receptors and mediates adiponectin signalling and function","volume":"8","author":"Mao","year":"2006","journal-title":"Nat. Cell Biol."},{"issue":"2012","key":"10.1016\/j.phrs.2016.12.003_bib1525","first-page":"107434","article-title":"Misregulation of PPAR functioning and its pathogenic consequences associated with nonalcoholic fatty liver disease in human obesity","author":"Videla","year":"2012","journal-title":"PPAR Res"},{"key":"10.1016\/j.phrs.2016.12.003_bib1530","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3892\/ijmm.2013.1560","article-title":"Metformin prevents hepatic steatosis by regulating the expression of adipose differentiation-related protein","volume":"33","author":"Liu","year":"2014","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.phrs.2016.12.003_bib1535","first-page":"139","article-title":"Metformin prevents non-alcoholic fatty liver disease in rats: role of phospholipase A2\/lysophosphatidylcholine lipoapoptosis pathway in hepatocytes","volume":"49","author":"Huang","year":"2011","journal-title":"Zhonghua Er Ke Za Zhi Chin. J. Pediatr."},{"key":"10.1016\/j.phrs.2016.12.003_bib1540","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.ejphar.2005.06.016","article-title":"Metformin reduces adiponectin protein expression and release in 3T3-L1 adipocytes involving activation of AMP activated protein kinase","volume":"518","author":"Huypens","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phrs.2016.12.003_bib1545","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1002\/dmrr.2580","article-title":"GLP-1 receptor agonists: effects on the progression of non-alcoholic fatty liver disease","volume":"31","author":"Liu","year":"2015","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.phrs.2016.12.003_bib1550","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1055\/s-0033-1358527","article-title":"The role of gastrointestinal hormones in hepatic lipid metabolism","volume":"33","author":"Mells","year":"2013","journal-title":"Semin. Liver Dis."},{"issue":"2012","key":"10.1016\/j.phrs.2016.12.003_bib1555","first-page":"716404","article-title":"The role of metformin in the management of NAFLD","author":"Mazza","year":"2012","journal-title":"Exp. Diabetes Res."},{"key":"10.1016\/j.phrs.2016.12.003_bib1560","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1002\/hep.28392","article-title":"Diet, weight loss, and liver health in nonalcoholic fatty liver disease: pathophysiology, evidence, and practice","volume":"63","author":"Marchesini","year":"2016","journal-title":"Hepatol. Baltim. Md."},{"issue":"2010","key":"10.1016\/j.phrs.2016.12.003_bib1565","first-page":"1255","article-title":"Metformin versus dietary treatment in nonalcoholic hepatic steatosis: a randomized study","volume":"34","author":"Garinis","year":"2005","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.phrs.2016.12.003_bib1570","first-page":"53","article-title":"Metformin in the treatment of non-alcoholic fatty liver disease: a meta-analysis","volume":"2","author":"De Lusong","year":"2006","journal-title":"Phil. J. Gastroenterol."},{"key":"10.1016\/j.phrs.2016.12.003_bib1575","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1586\/17474124.2014.894880","article-title":"Metformin in the treatment of non-alcoholic fatty liver disease: safety, efficacy and mechanism","volume":"8","author":"Rouabhia","year":"2014","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.phrs.2016.12.003_bib1580","unstructured":"Nonalcoholic Fatty Liver Disease (NAFLD) Pharmacological Treatment: Metformin Versus Atorvastatin - Full Text View - ClinicalTrials.gov, (n.d.). https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT01544751?term=metformin+AND+NAFLD&rank=2 (Accessed May 19 2016)"},{"key":"10.1016\/j.phrs.2016.12.003_bib1585","unstructured":"Efficacy Study of Liraglutide vs.Sitagliptin vs. Glargine on Liver Fat in T2DM Subjects - Full Text View - ClinicalTrials.gov, (n.d.). https:\/\/www.clinicaltrials.gov\/ct2\/show\/study\/NCT02147925?term=metformin+AND+NAFLD&rank=9 (Accessed May 19 2016)"},{"key":"10.1016\/j.phrs.2016.12.003_bib1590","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1093\/jn\/133.7.2180","article-title":"Butyrate impairs lipid transport by inhibiting microsomal triglyceride transfer protein in caco-2Cells","volume":"133","author":"Marcil","year":"2003","journal-title":"J. Nutr."},{"key":"10.1016\/j.phrs.2016.12.003_bib1595","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1002\/iub.110","article-title":"Gene expression analysis of a human enterocyte cell line reveals downregulation of cholesterol biosynthesis in response to short-chain fatty acids","volume":"60","author":"Alvaro","year":"2008","journal-title":"IUBMB Life"},{"key":"10.1016\/j.phrs.2016.12.003_bib1600","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1093\/jn\/131.7.1986","article-title":"Butyrate impairs energy metabolism in isolated perfused liver of fed rats","volume":"131","author":"Beauvieux","year":"2001","journal-title":"J. Nutr."},{"key":"10.1016\/j.phrs.2016.12.003_bib1605","doi-asserted-by":"publisher","first-page":"372","DOI":"10.3181\/00379727-177-41958","article-title":"Short-chain fatty acid fermentation products of plant fiber affect glucose metabolism of isolated rat hepatocytes","volume":"177","author":"Anderson","year":"1984","journal-title":"Proc. Soc. Exp. Biol. Med. Soc. Exp. Biol. Med. N. Y. N."},{"key":"10.1016\/j.phrs.2016.12.003_bib1610","doi-asserted-by":"publisher","first-page":"797","DOI":"10.2337\/db11-0846","article-title":"Sodium butyrate stimulates expression of fibroblast growth factor 21 in liver by inhibition of histone deacetylase 3","volume":"61","author":"Li","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.phrs.2016.12.003_bib1615","doi-asserted-by":"publisher","first-page":"10853","DOI":"10.1073\/pnas.0904187106","article-title":"FGF21 induces PGC-1alpha and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response","volume":"106","author":"Potthoff","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2016.12.003_bib1620","doi-asserted-by":"publisher","first-page":"2996","DOI":"10.1210\/en.2011-0281","article-title":"Integrated regulation of hepatic metabolism by fibroblast growth factor 21 (FGF21) in vivo","volume":"152","author":"Fisher","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.phrs.2016.12.003_bib1625","first-page":"1574","article-title":"Butyrate alleviates metabolic impairments and protects pancreatic \u03b2 cell function in pregnant mice with obesity","volume":"6","author":"Li","year":"2013","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.phrs.2016.12.003_bib1630","doi-asserted-by":"publisher","first-page":"887","DOI":"10.7754\/Clin.Lab.2013.130531","article-title":"Metformin suppresses lipid accumulation in skeletal muscle by promoting fatty acid oxidation","volume":"60","author":"Wang","year":"2014","journal-title":"Clin. Lab."},{"key":"10.1016\/j.phrs.2016.12.003_bib1635","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1001\/jama.2014.3315","article-title":"Effect of metformin on left ventricular function after acute myocardial infarction in patients without diabetes: the GIPS-III randomized clinical trial","volume":"311","author":"Lexis","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.phrs.2016.12.003_bib1640","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/(SICI)1520-7560(200001\/02)16:1<2::AID-DMRR75>3.0.CO;2-G","article-title":"Treatment with metformin of non-diabetic men with hypertension, hypertriglyceridaemia and central fat distribution: the BIGPRO 1.2 trial","volume":"16","author":"Charles","year":"2000","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.phrs.2016.12.003_bib1645","doi-asserted-by":"publisher","first-page":"e000090","DOI":"10.1136\/bmjdrc-2015-000090","volume":"3","author":"Lexis","year":"2015","journal-title":"BMJ Open Diabetes Res. Care."},{"key":"10.1016\/j.phrs.2016.12.003_bib1650","unstructured":"Glucose Lowering in Non-diabetic hyperglycaemia Trial\u202f: Overview, (n.d.). https:\/\/www.dtu.ox.ac.uk\/GLINT\/ (Accessed November 11 2016)"},{"key":"10.1016\/j.phrs.2016.12.003_bib1655","first-page":"A16764","article-title":"Abstract 16764: metformin use and clinical outcomes among patients with diabetes mellitus and heart failure or kidney dysfunction \u2013 observations from the SAVOR-TIMI 53 trial","volume":"134","author":"Bergmark","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2016.12.003_bib1660","article-title":"The sustained influence of metformin therapy on circulating GLP-1 levels in individuals with and without type 2 diabetes","author":"Preiss","year":"2016","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.phrs.2016.12.003_bib1665","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1590\/S0100-879X2006000400009","article-title":"Effects of metformin on the glycemic control, lipid profile, and arterial blood pressure of type 2 diabetic patients with metabolic syndrome already on insulin","volume":"39","author":"Mour\u00e3o-J\u00fanior","year":"2006","journal-title":"Braz. J. Med. Biol. Res. Rev. Bras. Pesqui."},{"key":"10.1016\/j.phrs.2016.12.003_bib1670","first-page":"CD002966","article-title":"Metformin monotherapy for type 2 diabetes mellitus","author":"Saenz","year":"2005","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.phrs.2016.12.003_bib1675","doi-asserted-by":"publisher","first-page":"23246","DOI":"10.1074\/jbc.M114.577908","article-title":"Metformin suppresses lipopolysaccharide (LPS)-induced inflammatory response in murine macrophages via activating transcription factor-3 (ATF-3) induction","volume":"289","author":"Kim","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2016.12.003_bib1680","doi-asserted-by":"publisher","first-page":"e71773","DOI":"10.1371\/journal.pone.0071773","article-title":"Metformin protects rat hepatocytes against bile acid-induced apoptosis","volume":"8","author":"Woudenberg-Vrenken","year":"2013","journal-title":"PLoS One."},{"key":"10.1016\/j.phrs.2016.12.003_bib1685","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.trsl.2015.06.002","article-title":"Metformin ameliorates the proinflammatory state in patients with carotid artery atherosclerosis through sirtuin 1 induction","volume":"166","author":"Xu","year":"2015","journal-title":"Transl. Res. J. Lab. Clin. Med."},{"key":"10.1016\/j.phrs.2016.12.003_bib1690","doi-asserted-by":"publisher","first-page":"196","DOI":"10.2174\/1871530315666150316124019","article-title":"Metformin and inflammation: its potential beyond glucose-lowering effect","volume":"15","author":"Saisho","year":"2015","journal-title":"Endocr. Metab. Immune Disord. Drug Targets"},{"key":"10.1016\/j.phrs.2016.12.003_bib1695","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1111\/j.1476-5381.2011.01230.x","article-title":"Metformin restores endothelial function in aorta of diabetic rats","volume":"163","author":"Sena","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2016.12.003_bib1700","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/joim.12128","article-title":"Long-term effects of metformin on endothelial function in type 2 diabetes: a randomized controlled trial","volume":"275","author":"de Jager","year":"2014","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.phrs.2016.12.003_bib1705","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.ijcard.2008.04.010","article-title":"Metformin inhibits TNF-alpha-induced IkappaB kinase phosphorylation, IkappaB-alpha degradation and IL-6 production in endothelial cells through PI3K-dependent AMPK phosphorylation","volume":"134","author":"Huang","year":"2009","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.phrs.2016.12.003_bib1710","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.diabres.2008.02.006","article-title":"The effect of metformin treatment on VEGF and PAI-1 levels in obese type 2 diabetic patients","volume":"81","author":"Ersoy","year":"2008","journal-title":"Diabetes Res Clin. Pract."},{"key":"10.1016\/j.phrs.2016.12.003_bib1715","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1055\/s-2003-38386","article-title":"Metformin, but not thiazolidinediones, inhibits plasminogen activator inhibitor-1 production in human adipose tissue in vitro","volume":"35","author":"He","year":"2003","journal-title":"Horm. Metab. Res. Horm. Stoffwechselforschung Horm. M\u00e9tabolisme"},{"key":"10.1016\/j.phrs.2016.12.003_bib1720","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.2337\/db15-0090","article-title":"Pleiotropic benefits of metformin: macrophage targeting its anti-inflammatory mechanisms","volume":"64","author":"Hattori","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.phrs.2016.12.003_bib1725","doi-asserted-by":"publisher","first-page":"696","DOI":"10.2337\/db07-1098","article-title":"Acute metformin therapy confers cardioprotection against myocardial infarction via AMPK-eNOS-mediated signaling","volume":"57","author":"Calvert","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.phrs.2016.12.003_bib1730","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.2337\/diabetes.54.5.1566","article-title":"Diabetes Prevention Program Research Group, Intensive lifestyle intervention or metformin on inflammation and coagulation in participants with impaired glucose tolerance","volume":"54","author":"Haffner","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.phrs.2016.12.003_bib1735","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1001\/jama.2009.1347","article-title":"Effects of initiating insulin and metformin on glycemic control and inflammatory biomarkers among patients with type 2 diabetes: the LANCET randomized trial","volume":"302","author":"Pradhan","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.phrs.2016.12.003_bib1740","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.ahj.2006.11.005","article-title":"A randomized trial of the effects of rosiglitazone and metformin on inflammation and subclinical atherosclerosis in patients with type 2 diabetes","volume":"153","author":"Stocker","year":"2007","journal-title":"Am. Heart J."},{"key":"10.1016\/j.phrs.2016.12.003_bib1745","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1161\/CIRCHEARTFAILURE.112.000162","article-title":"Comparative safety and effectiveness of metformin in patients with diabetes mellitus and heart failure: systematic review of observational studies involving 34,000 patients","volume":"6","author":"Eurich","year":"2013","journal-title":"Circ. Heart Fail"},{"key":"10.1016\/j.phrs.2016.12.003_bib1750","doi-asserted-by":"publisher","first-page":"425","DOI":"10.5551\/jat.15065","article-title":"Butyrate attenuates inflammation and lipolysis generated by the interaction of adipocytes and macrophages","volume":"20","author":"Ohira","year":"2013","journal-title":"J. Atheroscler. Thromb."},{"key":"10.1016\/j.phrs.2016.12.003_bib1755","doi-asserted-by":"crossref","first-page":"111","DOI":"10.31887\/DCNS.2009.11.2\/cqiu","article-title":"Epidemiology of Alzheimer\u2019s disease: occurrence, determinants, and strategies toward intervention","volume":"11","author":"Qiu","year":"2009","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.phrs.2016.12.003_bib1760","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.2337\/db14-0287","article-title":"Repurposing diabetes drugs for brain insulin resistance in Alzheimer disease","volume":"63","author":"Yarchoan","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.phrs.2016.12.003_bib1765","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S0140-6736(96)09328-2","article-title":"Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer\u2019s disease in the Rotterdam Study","volume":"349","author":"Hofman","year":"1997","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.phrs.2016.12.003_bib1770","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.ejphar.2008.02.049","article-title":"Diabetes and other vascular risk factors for dementia: which factor matters most? A systematic review","volume":"585","author":"Kloppenborg","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phrs.2016.12.003_bib1775","first-page":"373","article-title":"The relationship between Alzheimer\u2019s disease and diabetes: type 3 diabetes?","volume":"14","author":"Kroner","year":"2009","journal-title":"Altern. Med. Rev. J. Clin. Ther."},{"key":"10.1016\/j.phrs.2016.12.003_bib1780","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1001\/archneur.64.4.570","article-title":"Relation of diabetes to mild cognitive impairment","volume":"64","author":"Luchsinger","year":"2007","journal-title":"Arch. Neurol."},{"issue":"Pt A","key":"10.1016\/j.phrs.2016.12.003_bib1785","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.nbd.2014.09.001","article-title":"Insulin resistance in Alzheimer\u2019s disease","volume":"72","author":"Dineley","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.phrs.2016.12.003_bib1790","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.cobeha.2015.12.004","article-title":"Stop signs in hippocampal insulin signaling: the role of insulin resistance in structural, functional and behavioral deficits","volume":"9","author":"Fadel","year":"2016","journal-title":"Curr. Opin. Behav. Sci."},{"key":"10.1016\/j.phrs.2016.12.003_bib1795","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.pharmthera.2012.07.006","article-title":"Insulin in the brain: there and back again","volume":"136","author":"Banks","year":"2012","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.phrs.2016.12.003_bib1800","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/nrn3209","article-title":"The many faces of insulin-like peptide signalling in the brain","volume":"13","author":"Fernandez","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.phrs.2016.12.003_bib1805","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ejphar.2004.02.050","article-title":"The role of insulin and insulin-like growth factor I in the molecular and cellular mechanisms underlying the pathology of Alzheimer\u2019s disease","volume":"490","author":"Carro","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phrs.2016.12.003_bib1810","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/nrneurol.2010.130","article-title":"How does diabetes accelerate Alzheimer disease pathology?","volume":"6","author":"Sims-Robinson","year":"2010","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.phrs.2016.12.003_bib1815","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.neuropharm.2011.01.033","article-title":"Peripheral insulin-sensitizer drug metformin ameliorates neuronal insulin resistance and Alzheimer\u2019s-like changes","volume":"60","author":"Gupta","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.phrs.2016.12.003_bib1820","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.stem.2012.03.016","article-title":"Metformin activates an atypical PKC-CBP pathway to promote neurogenesis and enhance spatial memory formation","volume":"11","author":"Wang","year":"2012","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.phrs.2016.12.003_bib1825","doi-asserted-by":"publisher","first-page":"21830","DOI":"10.1073\/pnas.0912793107","article-title":"Biguanide metformin acts on tau phosphorylation via mTOR\/protein phosphatase 2A (PP2A) signaling","volume":"107","author":"Kickstein","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2016.12.003_bib1830","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.neuropharm.2015.07.023","article-title":"Antidiabetic drugs restore abnormal transport of amyloid-(across the blood-brain barrier and memory impairment in db\/db mice","volume":"101","author":"Chen","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.phrs.2016.12.003_bib1835","doi-asserted-by":"publisher","first-page":"3907","DOI":"10.1073\/pnas.0807991106","article-title":"Antidiabetic drug metformin (GlucophageR) increases biogenesis of Alzheimer\u2019s amyloid peptides via up-regulating BACE1 transcription","volume":"106","author":"Chen","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2016.12.003_bib1840","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbr.2015.12.012","article-title":"Prolonged metformin treatment leads to reduced transcription of Nrf2 and neurotrophic factors without cognitive impairment in older C57BL\/6J mice","volume":"301","author":"Allard","year":"2016","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.phrs.2016.12.003_bib1845","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3233\/JAD-2011-101524","article-title":"Incidence of dementia is increased in type 2 diabetes and reduced by the use of sulfonylureas and metformin","volume":"24","author":"Hsu","year":"2011","journal-title":"J. Alzheimers Dis. JAD"},{"key":"10.1016\/j.phrs.2016.12.003_bib1850","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1111\/j.1532-5415.2012.03916.x","article-title":"Metformin, other antidiabetic drugs, and risk of Alzheimer\u2019s disease: a population-based case-control study","volume":"60","author":"Imfeld","year":"2012","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.phrs.2016.12.003_bib1855","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.2337\/dc13-0229","article-title":"Increased risk of cognitive impairment in patients with diabetes is associated with metformin","volume":"36","author":"Moore","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.phrs.2016.12.003_bib1860","doi-asserted-by":"publisher","first-page":"501","DOI":"10.3233\/JAD-150493","article-title":"Metformin in amnestic mild cognitive impairment: results of a pilot randomized placebo controlled clinical trial","volume":"51","author":"Luchsinger","year":"2016","journal-title":"J. Alzheimers Dis. JAD."},{"key":"10.1016\/j.phrs.2016.12.003_bib1865","unstructured":"Effect of Insulin Sensitizer Metformin on AD Biomarkers - Full Text View - ClinicalTrials.gov, (n.d.). https:\/\/clinicaltrials.gov\/show\/NCT01965756 (Accessed May 20, 2016)"},{"key":"10.1016\/j.phrs.2016.12.003_bib1870","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1038\/npp.2009.197","article-title":"Inhibitors of class 1 histone deacetylases reverse contextual memory deficits in a mouse model of Alzheimer\u2019s disease","volume":"35","author":"Kilgore","year":"2010","journal-title":"Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.phrs.2016.12.003_bib1875","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3233\/JAD-2011-110080","article-title":"Sodium butyrate improves memory function in an Alzheimer\u2019s disease mouse model when administered at an advanced stage of disease progression","volume":"26","author":"Govindarajan","year":"2011","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.phrs.2016.12.003_bib1880","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3389\/fnins.2014.00160","article-title":"Histone-acetylation: a link between Alzheimer\u2019s disease and post-traumatic stress disorder?","volume":"8","author":"Bahari-Javan","year":"2014","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.phrs.2016.12.003_bib1885","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1089\/rej.2011.1153","article-title":"Metformin as a geroprotector","volume":"14","author":"Bulterijs","year":"2011","journal-title":"Rejuvenation Res."},{"key":"10.1016\/j.phrs.2016.12.003_bib1890","doi-asserted-by":"publisher","first-page":"320","DOI":"10.18632\/aging.100455","article-title":"Metformin in obesity, cancer and aging: addressing controversies","volume":"4","author":"Berstein","year":"2012","journal-title":"Aging (Milano)"},{"key":"10.1016\/j.phrs.2016.12.003_bib1895","article-title":"Frailty attenuates the impact of metformin on reducing mortality in older adults with type 2 diabetes","volume":"2","author":"Wang","year":"2014","journal-title":"J. Endocrinol. Diabetes Obes."},{"key":"10.1016\/j.phrs.2016.12.003_bib1900","doi-asserted-by":"publisher","first-page":"6S36","DOI":"10.1016\/S1262-3636(03)72786-4","article-title":"Improving survival with metformin: the evidence base today","volume":"29","author":"Scarpello","year":"2003","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.phrs.2016.12.003_bib1905","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1634\/theoncologist.2013-0111","article-title":"Metformin is associated with survival benefit in cancer patients with concurrent type 2 diabetes: a systematic review and meta-analysis","volume":"18","author":"Yin","year":"2013","journal-title":"Oncologist"},{"key":"10.1016\/j.phrs.2016.12.003_bib1910","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.oraloncology.2015.01.007","article-title":"Effects of metformin on head and neck cancer: a systematic review","volume":"51","author":"R\u00eago","year":"2015","journal-title":"Oral Oncol."},{"key":"10.1016\/j.phrs.2016.12.003_bib1915","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a025932","article-title":"Metformin: a hopeful promise in aging research","volume":"6","author":"Novelle","year":"2016","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.phrs.2016.12.003_bib1920","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.numecd.2015.03.007","article-title":"Metformin improves putative longevity effectors in peripheral mononuclear cells from subjects with prediabetes. A randomized controlled trial","volume":"25","author":"de Kreutzenberg","year":"2015","journal-title":"Nutr. Metab. Cardiovasc. Dis. NMCD."},{"key":"10.1016\/j.phrs.2016.12.003_bib1925","unstructured":"Metformin in Longevity Study - Full Text View - ClinicalTrials.gov, (n.d.). https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT02432287?term=metformin+AND+MILES+study&rank=1 (Accessed May 20, 2016)"},{"key":"10.1016\/j.phrs.2016.12.003_bib1930","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.maturitas.2013.02.004","article-title":"Probiotics and prebiotics and health in ageing populations","volume":"75","author":"Duncan","year":"2013","journal-title":"Maturitas"},{"key":"10.1016\/j.phrs.2016.12.003_bib1935","doi-asserted-by":"publisher","first-page":"224","DOI":"10.3389\/fgene.2012.00224","article-title":"Epigenetic drugs: a novel anti-aging strategy?","volume":"3","author":"Vaiserman","year":"2012","journal-title":"Front. Genet."},{"key":"10.1016\/j.phrs.2016.12.003_bib1940","first-page":"126","article-title":"Effect of the histone deacetylase inhibitor sodium butyrate on the viability and life span in Drosophila melanogaster","volume":"25","author":"Va\u012dserman","year":"2012","journal-title":"Adv. Gerontol. Uspekhi Gerontol. Ross. Akad. Nauk Gerontol. Obshchestvo"},{"key":"10.1016\/j.phrs.2016.12.003_bib1945","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1242\/jeb.01439","article-title":"Lifespan extension and elevated hsp gene expression in Drosophila caused by histone deacetylase inhibitors","volume":"208","author":"Zhao","year":"2005","journal-title":"J. Exp. Biol."},{"key":"10.1016\/j.phrs.2016.12.003_bib1950","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/srep00362","article-title":"Metformin kills and radiosensitizes cancer cells and preferentially kills cancer stem cells","volume":"2","author":"Song","year":"2012","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2016.12.003_bib1955","doi-asserted-by":"publisher","first-page":"6741","DOI":"10.1158\/1078-0432.CCR-13-1787","article-title":"Reprogramming metabolism with metformin improves tumor oxygenation and radiotherapy response","volume":"19","author":"Zannella","year":"2013","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.phrs.2016.12.003_bib1960","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.ijrobp.2015.06.003","article-title":"Metformin: a novel biological modifier of tumor response to radiation therapy","volume":"93","author":"Koritzinsky","year":"2015","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.phrs.2016.12.003_bib1965","unstructured":"Advanced Lung Cancer Treatment With Metformin and Chemo-Radiotherapy - Full Text View - ClinicalTrials.gov, (n.d.). https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT02115464?term=radiotherapy+AND+metformin&rank=1 (Accessed May 20, 2016)"},{"key":"10.1016\/j.phrs.2016.12.003_bib1970","unstructured":"Metformin in Non Small Cell Lung Cancer (NSCLC) - Full Text View - ClinicalTrials.gov, (n.d.). https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT02285855?term=radiotherapy+AND+metformin&rank=5 (Accessed May 20, 2016)"},{"key":"10.1016\/j.phrs.2016.12.003_bib1975","unstructured":"Placebo Controlled Double Blind Crossover Trial of Metformin for Brain Repair in Children With Cranial-Spinal Radiation for Medulloblastoma - Full Text View - ClinicalTrials.gov, (n.d.). https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT02040376?term=radiotherapy+AND+metformin&rank=7 (Accessed May 20, 2016)"},{"key":"10.1016\/j.phrs.2016.12.003_bib1980","unstructured":"Chemotherapy and Radiation Therapy With or Without Metformin Hydrochloride in Treating Patients With Stage III Non-small Cell Lung Cancer - Full Text View - ClinicalTrials.gov, (n.d.). https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT02186847?term=radiotherapy+AND+metformin&rank=2 (Accessed May 20, 2016)"},{"key":"10.1016\/j.phrs.2016.12.003_bib1985","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1016\/S0140-6736(00)02787-2","article-title":"Topical butyrate for acute radiation proctitis: randomised crossover trial","volume":"356","author":"Vernia","year":"2000","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.phrs.2016.12.003_bib1990","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1007\/s00066-008-1896-1","article-title":"Sodium butyrate enemas in the treatment of acute radiation-induced proctitis in patients with prostate cancer and the impact on late proctitis. A prospective evaluation, Strahlenther","volume":"184","author":"Hille","year":"2008","journal-title":"Strahlenther. Onkol. Organ Dtsch. R\u00f6ntgenges. Al."},{"key":"10.1016\/j.phrs.2016.12.003_bib1995","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.ijrobp.2014.03.018","article-title":"Daily sodium butyrate enema for the prevention of radiation proctitis in prostate cancer patients undergoing radical radiation therapy: results of a multicenter randomized placebo-controlled dose-finding phase 2 study","volume":"89","author":"Maggio","year":"2014","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.phrs.2016.12.003_bib2000","doi-asserted-by":"publisher","first-page":"4116","DOI":"10.1210\/jc.2003-030424","article-title":"Metformin or antiandrogen in the treatment of hirsutism in polycystic ovary syndrome","volume":"88","author":"Harborne","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.phrs.2016.12.003_bib2005","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1210\/jc.2007-2429","article-title":"Clinical review: insulin sensitizers for the treatment of hirsutism: a systematic review and metaanalyses of randomized controlled trials","volume":"93","author":"Cosma","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.phrs.2016.12.003_bib2010","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1093\/humrep\/dem005","article-title":"Metformin versus oral contraceptive pill in polycystic ovary syndrome: a Cochrane review","volume":"22","author":"Costello","year":"2007","journal-title":"Hum. Reprod. Oxf. Engl."},{"key":"10.1016\/j.phrs.2016.12.003_bib2015","first-page":"CD010334","article-title":"Interventions for hirsutism (excluding laser and photoepilation therapy alone)","volume":"4","author":"van Zuuren","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.phrs.2016.12.003_bib2020","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1095\/biolreprod.110.087023","article-title":"Metformin decreases GnRH- and activin-induced gonadotropin secretion in rat pituitary cells: potential involvement of adenosine 5\u2032 monophosphate-activated protein kinase (PRKA)","volume":"84","author":"Tosca","year":"2011","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.phrs.2016.12.003_bib2025","doi-asserted-by":"publisher","first-page":"E1491","DOI":"10.1210\/jc.2013-1865","article-title":"Metformin inhibits follicle-stimulating hormone (FSH) action in human granulosa cells: relevance to polycystic ovary syndrome","volume":"98","author":"Rice","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.phrs.2016.12.003_bib2030","doi-asserted-by":"publisher","first-page":"E1262","DOI":"10.1210\/jc.2011-0555","article-title":"Early metformin therapy (age 8\u201312 years) in girls with precocious pubarche to reduce hirsutism, androgen excess, and oligomenorrhea in adolescence","volume":"96","author":"Ib\u00e1\u00f1ez","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.phrs.2016.12.003_bib2035","doi-asserted-by":"publisher","first-page":"2888","DOI":"10.1210\/jc.2006-0336","article-title":"Metformin treatment to prevent early puberty in girls with precocious pubarche","volume":"91","author":"Ib\u00e1\u00f1ez","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.phrs.2016.12.003_bib2040","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1210\/jc.2005-2329","article-title":"Metformin therapy during puberty delays menarche, prolongs pubertal growth, and augments adult height: a randomized study in low-birth-weight girls with early-normal onset of puberty","volume":"91","author":"Ib\u00e1\u00f1ez","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.phrs.2016.12.003_bib2045","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/nrendo.2014.40","article-title":"Pros and cons of GnRHa treatment for early puberty in girls","volume":"10","author":"Willemsen","year":"2014","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.phrs.2016.12.003_bib2050","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.ijpharm.2014.12.009","article-title":"Pulmonary drug delivery systems for tuberculosis treatment","volume":"478","author":"Pham","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.phrs.2016.12.003_bib2055","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/nnano.2016.38","article-title":"A graphene-based electrochemical device with thermoresponsive microneedles for diabetes monitoring and therapy","volume":"11","author":"Lee","year":"2016","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.phrs.2016.12.003_bib2060","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1136\/gut.28.10.1221","article-title":"Short chain fatty acids in human large intestine portal, hepatic and venous blood","volume":"28","author":"Cummings","year":"1987","journal-title":"Gut"},{"key":"10.1016\/j.phrs.2016.12.003_bib2065","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1507\/endocrj.47.373","article-title":"The functional significance of Shc in insulin signaling as a substrate of the insulin receptor","volume":"47","author":"Sasaoka","year":"2000","journal-title":"Endocr. J."},{"key":"10.1016\/j.phrs.2016.12.003_bib2070","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s10549-010-0763-9","article-title":"Metformin and rapamycin have distinct effects on the AKT pathway and proliferation in breast cancer cells","volume":"123","author":"Zakikhani","year":"2010","journal-title":"Breast Cancer Res. Treat."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661816309549?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661816309549?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T10:20:16Z","timestamp":1749810016000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661816309549"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":414,"alternative-id":["S1043661816309549"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2016.12.003","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A story of metformin-butyrate synergism to control various pathological conditions as a consequence of gut microbiome modification: Genesis of a wonder drug?","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2016.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}